<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genomics</journal-id><journal-id journal-id-type="iso-abbrev">Genomics</journal-id><journal-title-group><journal-title>Genomics</journal-title></journal-title-group><issn pub-type="ppub">0888-7543</issn><issn pub-type="epub">1089-8646</issn><publisher><publisher-name>Elsevier Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7381398</article-id><article-id pub-id-type="pii">S0888-7543(20)30895-8</article-id><article-id pub-id-type="doi">10.1016/j.ygeno.2020.07.033</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minireview</subject></subj-group></article-categories><title-group><article-title>Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name><surname>Sharma</surname><given-names>Namisha</given-names></name><xref rid="af0005" ref-type="aff">a</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au0010"><name><surname>Muthamilarasan</surname><given-names>Mehanathan</given-names></name><xref rid="af0010" ref-type="aff">b</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au0015"><name><surname>Prasad</surname><given-names>Ashish</given-names></name><xref rid="af0005" ref-type="aff">a</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au0020"><name><surname>Prasad</surname><given-names>Manoj</given-names></name><xref rid="af0005" ref-type="aff">a</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib><aff id="af0005"><label>a</label>National Institute of Plant Genome Research, Aruna Asaf Ali Marg, New Delhi 110067, India</aff><aff id="af0010"><label>b</label>Department of Plant Sciences, School of Life Sciences, University of Hyderabad, Hyderabad 500046, Telangana, India</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author.</corresp><fn id="fn0005"><label>1</label><p id="np0005">These authors contributed equally.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>25</day><month>7</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>11</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>25</day><month>7</month><year>2020</year></pub-date><volume>112</volume><issue>6</issue><fpage>4322</fpage><lpage>4331</lpage><history><date date-type="received"><day>1</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>10</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Elsevier Inc. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier Inc.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="ab0005"><p>COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is devastative to the humankind for which neither vaccines nor precise therapeutic molecules for treatment are identified. The search for new drugs and repurposing of existing drugs are being performed; however, at the same time, research on plants to identify novel therapeutic compounds or testing the existing ones is progressing at a slower phase. In this context, genomics and biotechnology offer various tools and strategies to manipulate plants for producing those complex biopharmaceutical products. This review enumerates the scope for research on plant-based molecules for their potential application in treating SARS-CoV-2 infection. Strategies to edit gene and genome, overexpression and silencing approaches, and molecular breeding for producing target biomolecules in the plant system are discussed in detail. Altogether, the present review provides a roadmap for expediting research on using plants as a novel source of active biomolecules having therapeutic applications.</p></abstract><abstract abstract-type="author-highlights" id="ab0010"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="li0005"><label>&#x02022;</label><p id="p0005">Plants are a source of biomolecules that have application in treatment of SARS-CoV-2.</p></list-item><list-item id="li0010"><label>&#x02022;</label><p id="p0010">Identifying active biomolecules for therapeutic purposes is not adequately performed.</p></list-item><list-item id="li0015"><label>&#x02022;</label><p id="p0015">High-throughput strategies promote large-scale screening of plant-based drugs.</p></list-item><list-item id="li0020"><label>&#x02022;</label><p id="p0020">Plant biotechnology facilitates the production of complex biopharmaceutical products.</p></list-item></list></p></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>SARS-CoV-2</kwd><kwd>Coronavirus</kwd><kwd>Genomics</kwd><kwd>Genetic manipulation</kwd><kwd>Therapeutics</kwd><kwd>Plant-based drugs</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0025">Advancement of civilization at a rapid pace faces the spread of complex diseases and infections that threatens the human race. Among the diseases, several pandemics have wiped a predominant human population throughout history. To note a few, flu, plague, pox, yellow fever, malaria, leprosy, tuberculosis, measles, dengue, HIV/AIDS, H1N1, SARS, Ebola, and MERS were disastrous. Among these, the present-day COVID-19 (caused by Severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) is potentially contagious and lethal that has forced almost all the countries to practice a strict lockdown for minimizing the spread [<xref rid="bb0345" ref-type="bibr">69</xref>]. The virulence of this virus, along with the evolution of different strains, has urged the scientific community to identify vaccines, therapeutic drugs, and diagnostic methods for rapid detection, treatment, and immunization of the human population. Though progress has been made in the development of biological- and chemical-based strategies to diagnose the disease, there is no drug or vaccine invented so far to treat the infected patients effectually [<xref rid="bb0275" ref-type="bibr">55</xref>]. The appearance of disease symptoms at a late stage and the issue of asymptomatic infections have constrained the diagnosis procedures; however, testing the entire population for the virus infection holds the key to identify the infected ones, isolate and treat them in a suitable way (WHO, 2020). In case of treatment of infected patients, the use of existing antiviral drugs is prevalent, and also, repurposing of drugs is suggested for testing and application. Currently, antiviral drugs such as Lopinavir/Ritonavir and Remdesivir are predominantly used in the treatment. These commercially synthesized molecules inhibit the virus replication either by regulating the ion channel transport or inhibiting the serine protease activity [<xref rid="bb0080" ref-type="bibr">16</xref>,<xref rid="bb0485" ref-type="bibr">97</xref>]. However, the search for novel compounds that could interfere with viral replication, assembly, and spread within the human system is in progress. Devising new molecules through computational and integrative approaches that target one or the other process of virus infection and spread could be an amenable strategy. Still, the chemical synthesis of such a molecule is time-consuming and labor-intensive. Screening of existing molecules for repurposing is already being carried out, but at the same time, studying the plants for novel phytochemicals that possess potential antiviral activity is largely ignored.</p><p id="p0030">Large-scale screening of plants for active antiviral compounds dates to 1952, where around 288 plant extracts were tested for their activity against influenza A virus [<xref rid="bb0055" ref-type="bibr">11</xref>]. Later, Debiaggi et al. [<xref rid="bb0095" ref-type="bibr">19</xref>] had shown the antiviral effect of <italic>Chamaecyparis lawsoniana</italic> on herpes simplex virus type 2. Similarly, Serkedjieva [<xref rid="bb0390" ref-type="bibr">78</xref>] identified the antiviral effect of <italic>Geranium sanguineum</italic> extract against influenza A virus, and Asres and Bucar [<xref rid="bb0015" ref-type="bibr">3</xref>] showed anti-HIV activity of <italic>Combretum mole</italic>. An aqueous extract of <italic>Agrimonia eupatoria</italic> and root extract of <italic>Boehmeria nivea</italic> were reported to inhibit hepatitis B virus [<xref rid="bb0160" ref-type="bibr">32</xref>,<xref rid="bb0235" ref-type="bibr">47</xref>]. Kotwal et al. [<xref rid="bb0215" ref-type="bibr">43</xref>] had demonstrated that an acidic extract of <italic>Trifolium</italic> species could show a broad-spectrum antiviral activity, including anti-SARS activity. Thus, examining natural antiviral compounds from plants gains momentum in the present scenario. These plant-based therapeutic drugs have several advantages as compared to synthetic molecules. Naturally available biomolecules are safe, economical, and have minimal side effects. Further, if a plant-based compound is found to regulate the COVID-19 infection, it can facilitate an immediate use in the treatment regime after obtaining necessary ethical clearances. However, these compounds might not be stable or produced at minimal levels since they might play limited roles <italic>in planta</italic>. A holistic approach is required to identify such potential compounds, study the biosynthesis pathway, analyze the genes underlying those pathways, and finetuning them using genomics and biotechnological interventions could promote the use of plants as a source and bio-manufacturer of antiviral compounds in large-scale. While mainstreaming plant-based research to identify biomolecules having anti-SARS-CoV-2 activity itself is in a nascent stage, exploiting the potential plants as biofactories is a long way to go. However, the advent of tools and techniques in plant molecular biology and biotechnology could expedite this process provided a roadmap need to be established towards achieving these targets. Given this, the present review enumerates the plant-based compounds that have been identified and characterized so far for treating viral infections with emphasis on coronavirus strains. The strategies for the identification of additional compounds, implementing omics tools for the over-production of those compounds, customization of biomolecules, and scaling-up of the process for large-scale production have been elaborated. Altogether, the review provides a roadmap for extrapolating the biomolecule repertoire of plants and use genomics and biotechnological approaches for their production and effective use in SARS-CoV-2 treatments.</p></sec><sec id="s0010"><label>2</label><title>Plant-based biomolecules with antiviral activities</title><p id="p0035">Presently, traditional medicines from different parts of the world have been studied for their therapeutic effect against SARS-CoV-2. Traditional medicines-based defense methodology has been used against different human viruses, including SARS-CoV, Ebola, and Zika viruses [<xref rid="bb0505" ref-type="bibr">101</xref>]. Recently, Sehailia and Chemat [<xref rid="bb0385" ref-type="bibr">77</xref>] had compared the mechanism of infection of SARS-CoV-2 and malaria plasmodium and found that both the pathogens infect the lungs to cause the crystallization of carbon dioxide. Based on this information, artemisinin molecule (sesquiterpene lactone), isolated from <italic>Artemisia annua,</italic> has been proposed to be used in the treatment of SARS-CoV-2 patients. Artemisinin is popularly used in treating malaria; however, it has also been tested for its activity against different viral diseases, including MERS-CoV and SARS-CoV [<xref rid="bb0090" ref-type="bibr">18</xref>,<xref rid="bb0135" ref-type="bibr">27</xref>]. Currently, WHO has backed the clinical trials on <italic>Artemisia annua</italic> for its use in treating COVID-19, and collaborative research in this direction is being performed at Max-Planck research center, Germany and Mateon Therapeutics, California. The use of medicinal plants for treating infectious diseases is found to be associated with the tradition and custom of several populations around the globe. For example, Traditional Chinese Medicine (TCM) is one of the well-studied and documented practices followed in China that has been reported to cure many diseases or infections, including SARS-CoV [<xref rid="bb0255" ref-type="bibr">51</xref>,<xref rid="bb0445" ref-type="bibr">89</xref>,<xref rid="bb0520" ref-type="bibr">104</xref>]. Approximately 85% of COVID-19 patients were treated with TCM that might act due to a close homology between SARS-CoV-2 and SARS-CoV [<xref rid="bb0505" ref-type="bibr">101</xref>]. These plants could possess active biomolecules that regulate virus accumulation by restricting their multiplication. For example, flavonoids (herbacetin, isobavaschalcone, rhoifolin, pectolinarin, quercetin 3-&#x003b2;-D-glucoside, and epigallocatechin gallate) were found inhibit the enzymatic activity of one of the viral proteases; MERS-CoV 3CL protease and myricetin and scutellarein have the potential to regulate the helices activity of nsP13 (SARS-CoV helicase protein). Yang et al. [<xref rid="bb0505" ref-type="bibr">101</xref>] had reported that at least fifteen clinical trials are underway to test the efficacy of TCM in treating SARS-CoV-2 infection.</p><p id="p0040">Countries other than China focus very less on their traditional medicinal plants that could be a potential source of active antiviral molecules. For example, India has a long record of using plants in treating virus-induced respiratory diseases; however, further research towards pinpointing the molecules having roles in antiviral activity is limited. A few Indian collections of medicinal herbs were reported to demonstrate anti-inflammatory and antioxidant properties and can be used for the treatment of COVID-19 [<xref rid="bb0460" ref-type="bibr">92</xref>]. For instance, <italic>Vitex trifolia</italic> and <italic>Sphaeranthus indicus</italic>, the medicinal plants from Southern India, have been reported to target cytokines, thus reducing the inflammation during respiratory diseases, including SARS-CoV at a concentration of 400&#x000a0;ng/mL [<xref rid="bb0430" ref-type="bibr">86</xref>]. Similarly, several species used in the daily diet contain metabolites such as curcumin and quercetin, which were found to interact with proteases of SARS-CoV-2 [<xref rid="bb0380" ref-type="bibr">76</xref>]. Further, Unani medicine, having an antiviral effect against measles and similar virus disease, has been proposed to provide an inhibitory effect on SARS-CoV-2 [<xref rid="bb0310" ref-type="bibr">62</xref>]. The antiviral compounds reported so far in plant species are summarized in <xref rid="t0005" ref-type="table">Table 1</xref>
, and their target sites of action on SARS-CoV-2 are shown in <xref rid="f0005" ref-type="fig">Fig. 1</xref>
. In addition to antiviral activity, plant extracts also possess antioxidant, antipyretic, anti-asthmatic, bronchodilator, expectorant, analgesic, and anti-inflammatory activities that have application in the treatment regime of respiratory diseases (<xref rid="t0010" ref-type="table">Table 2</xref>
). Several herbs have been reported to possess immune-boosting properties, and this includes <italic>Ocimum tenuiflorum</italic>, <italic>Zingiber officinale</italic>, <italic>Trigonella foenum-graecum</italic>, <italic>Allium sativum</italic>, and <italic>Curcuma longa</italic>. However, there is no comprehensive study performed to identify the active biomolecules that interact with the immune system of the human body to enhance the resistance to diseases. The prevalence of COVID-19 as a pandemic has mandated research and development for identifying vaccines, therapeutic and diagnostic molecules; however, such searching for those biomolecules in plants is not being performed at the right pace. In case of plant-based vaccines, research is appropriately being carried out to express novel virus-like particles (VLP) in plants that could serve as potential antigens for eliciting immune responses. The prime advantages of plant-based vaccines are their purity (free from human pathogens), low cost for production, transportation, and storage [<xref rid="bb0350" ref-type="bibr">70</xref>]. In case of diagnostic reagents, plants serve as a suitable host for expressing viral proteins to develop assay kits for effective detection and diagnosis of SARS-CoV-2 (reviewed in [<xref rid="bb0050" ref-type="bibr">10</xref>]). Given this, the review explicitly covers the identification and isolation of plant-based therapeutic molecules and the role of genomics and biotechnology in reaping the maximum benefit out of plants for effective treatment of potential diseases.<table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>Plant-based compounds reported to possess antiviral activity.</p></caption><alt-text id="al0020">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Plant</th><th>Compound</th><th>Target</th><th>Mode of action</th><th>Reference</th></tr></thead><tbody><tr><td><italic>Allium sativum</italic></td><td>Allyl disulfide</td><td>S protein</td><td>ACE2 receptor inhibitor</td><td>[<xref rid="bb0435" ref-type="bibr">87</xref>].</td></tr><tr><td><italic>Anethum graveolens</italic></td><td>Quercetin</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb0185" ref-type="bibr">37</xref>]</td></tr><tr><td><italic>Artemisia annua</italic></td><td>Aurantiamide acetate</td><td>Inhibition of CoV protease</td><td>Virus replication</td><td>[<xref rid="bb0315" ref-type="bibr">63</xref>]</td></tr><tr><td><italic>Broussonetia papyrifera</italic></td><td>3&#x02032;-(3-methylbut-2-enyl)-3&#x02032;,4,7-trihydroxyflavane</td><td>Inhibition of CoV protease</td><td>Virus replication</td><td>[<xref rid="bb0330" ref-type="bibr">66</xref>]</td></tr><tr><td rowspan="2"><italic>Camellia sinensis</italic></td><td>3-Isotheaflavin-3-gallate</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb0060" ref-type="bibr">12</xref>]</td></tr><tr><td>Theaflavin</td><td>RNA-dependent RNA polymerase</td><td>Virus replication</td><td>[<xref rid="bb0270" ref-type="bibr">54</xref>]</td></tr><tr><td><italic>Cinnamomi sp.</italic></td><td>Procyanidin A2</td><td>&#x02013;</td><td>Inhibition of virus entry</td><td>[<xref rid="bb0540" ref-type="bibr">108</xref>]</td></tr><tr><td><italic>Curcuma longa</italic></td><td>Demethoxycurcumine</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb0185" ref-type="bibr">37</xref>]</td></tr><tr><td><italic>Dioscoreae Rhizoma</italic></td><td>&#x02013;</td><td>&#x02013;</td><td>Inhibition of virus growth</td><td>[<xref rid="bb0495" ref-type="bibr">99</xref>]</td></tr><tr><td rowspan="2"><italic>Galla chinensis</italic></td><td>Tetra-O-galloyl&#x003b2;-<sc>d</sc>-glucose</td><td>S protein</td><td>ACE2 receptor inhibitor</td><td rowspan="2">[<xref rid="bb0510" ref-type="bibr">102</xref>]</td></tr><tr><td>Luteolin</td><td>Spike protein</td><td>Virus entry</td></tr><tr><td><italic>Griffithsia sp.</italic></td><td>Griffithsin</td><td>Spike protein</td><td>Inhibition of virus entry</td><td>[<xref rid="bb0295" ref-type="bibr">59</xref>]</td></tr><tr><td><italic>Isatis indigotica</italic></td><td>Aloe emodin</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb0245" ref-type="bibr">49</xref>]</td></tr><tr><td><italic>Linum usitatissimum</italic></td><td>Herbacetin</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb0180" ref-type="bibr">36</xref>]</td></tr><tr><td><italic>Lycoris radiata</italic></td><td>Lycorine</td><td>&#x02013;</td><td>Inhibited cell divison</td><td>-[<xref rid="bb0395" ref-type="bibr">79</xref>]</td></tr><tr><td><italic>Malus domestica</italic></td><td>Apigenin</td><td>main protease (M<sup>pro</sup>)</td><td>Inhibited virus replication</td><td>[<xref rid="bb0380" ref-type="bibr">76</xref>]</td></tr><tr><td><italic>Olea europaea L</italic><break/><italic>Averrhoa belimbi</italic><break/><italic>Capsicum annum</italic><break/><italic>Allium fistulosum</italic></td><td>Luteolin-7-glucoside</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb0185" ref-type="bibr">37</xref>]</td></tr><tr><td><italic>Rheum officinale</italic></td><td>Emodin</td><td>Inhibited binding of S protein to ACE2</td><td>Virus entry</td><td>[<xref rid="bb0440" ref-type="bibr">88</xref>]</td></tr><tr><td><italic>Salvia miltiorrhiza</italic></td><td>Tanshinone IIA/B</td><td>Inhibition of CoV protease</td><td>Virus replication</td><td>[<xref rid="bb0325" ref-type="bibr">65</xref>]</td></tr><tr><td><italic>Salvia officinalis</italic></td><td>Safficinolide</td><td>main protease (M<sup>pro</sup>)</td><td>Inhibited virus replication</td><td>[<xref rid="bb0380" ref-type="bibr">76</xref>]</td></tr><tr><td><italic>Stephania tetrandra</italic></td><td>Tetrandrine</td><td>S and N protein</td><td>Virus replication</td><td>[<xref rid="bb0200" ref-type="bibr">40</xref>]</td></tr><tr><td><italic>Torreya nucifera</italic></td><td>Amentoflavone, Apigenin</td><td>main protease (M<sup>pro</sup>)</td><td>Virus replication</td><td>[<xref rid="bb1000" ref-type="bibr">109</xref>]</td></tr><tr><td><italic>Tripterygium regelii</italic></td><td>Celastrol</td><td>Inhibition of CoV protease</td><td>Virus replication</td><td>[<xref rid="bb0370" ref-type="bibr">74</xref>]</td></tr><tr><td><italic>Urtica dioica</italic></td><td>agglutinin</td><td>Spike protein</td><td>Inhibition of virus entry</td><td>[<xref rid="bb0225" ref-type="bibr">45</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>&#x02018;-&#x02018;No information available.</p></fn></table-wrap-foot></table-wrap><fig id="f0005"><label>Fig. 1</label><caption><p>Structural proteins of SARS-CoV-2 and the potential plant-based biomolecules interacting with these proteins. The mode of action of these biomolecules are given in <xref rid="t0005" ref-type="table">Table 1</xref>, <xref rid="t0010" ref-type="table">Table 2</xref>.</p></caption><alt-text id="al0005">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig><table-wrap position="float" id="t0010"><label>Table 2</label><caption><p>Potential plant-based biomolecules useful for therapeutic applications to treat SARS-CoV-2.</p></caption><alt-text id="al0025">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Compound</th><th>Source</th><th>Class</th><th>Mode of action</th><th>Reference</th></tr></thead><tbody><tr><td colspan="5">Anti-asthmatic compounds</td></tr><tr><td>1,8-Cineol</td><td><italic>Eucalyptus globulus</italic></td><td>Monoterpene</td><td>NF-&#x003ba;B p65 translocation to nucleus is inhibited thus, hampering NF-&#x003ba;B mediated transcription.</td><td>[<xref rid="bb0120" ref-type="bibr">24</xref>]</td></tr><tr><td>3-Methoxy-catalposide</td><td><italic>Pseudolysimachion rotundum</italic></td><td>Iridoid glycoside</td><td>Inhibitory effect on lipopolysaccharide stimulated RAW264.7 macrophages.</td><td>[<xref rid="bb0365" ref-type="bibr">73</xref>]</td></tr><tr><td>7-Glucuronic acid-5,6-dihydroxyflavone</td><td><italic>Scutellaria baicalensis</italic></td><td>Flavonoid</td><td>Inhibitor of phosphodiesterase 4A and 4B. Downregulates the expression of TNF-&#x003b1;.</td><td>[<xref rid="bb0335" ref-type="bibr">67</xref>]</td></tr><tr><td>5,7-dihydroxyflavon</td><td><italic>Passiflora caerulea</italic></td><td>Flavonoid</td><td>Suppression of mast cell mediated release of pro-inflammatory cytokines.</td><td>[<xref rid="bb0030" ref-type="bibr">6</xref>]</td></tr><tr><td>Crocetin</td><td><italic>Crocus sativus</italic></td><td>Carotenoid</td><td>Asthma mitigation by activation of Foxp3 through TIPE2 in asthma associated Treg cells.</td><td>[<xref rid="bb0100" ref-type="bibr">20</xref>]</td></tr><tr><td>Curcumin</td><td><italic>Curcuma longa</italic></td><td>Polyphenol</td><td>Inhibition of Notch1&#x02013;GATA3 signalling pathway preventing the development of allergic airway inflammation.</td><td>[<xref rid="bb0075" ref-type="bibr">15</xref>]</td></tr><tr><td>Diallyl-disulfide</td><td><italic>Zingiber officinale</italic></td><td>Organosulphur</td><td>Suppression of airway inflammation by activation of Nrf-2/HO-1 pathway and downregulation of NF-kappaB.</td><td>[<xref rid="bb0410" ref-type="bibr">82</xref>]</td></tr><tr><td>D-&#x003b1;-tocopheryl acetate</td><td><italic>Glycine</italic> max</td><td>Vitamin</td><td>Modulates atopic asthma and inhibits oxidative stress.</td><td>[<xref rid="bb0155" ref-type="bibr">31</xref>]</td></tr><tr><td>Ellagic acid</td><td><italic>Rubus fruticosus</italic></td><td>Polyphenol</td><td>Inhibition of NF-&#x003ba;B mediated transcription</td><td>[<xref rid="bb0530" ref-type="bibr">106</xref>]</td></tr><tr><td>1,3,8-Trihydroxy-6-methylanthraquinone</td><td><italic>Rheum palmatum</italic></td><td>Anthraquinone</td><td>Inhibition of NF-&#x003ba;B signalling pathway</td><td>[<xref rid="bb0415" ref-type="bibr">83</xref>]</td></tr><tr><td>Homoegonol</td><td><italic>Styrax japonica</italic></td><td>Lignan</td><td>Reduction in the number of inflammatory cells and Th2 cytokines</td><td>[<xref rid="bb0405" ref-type="bibr">81</xref>]</td></tr><tr><td>Kaempferol-O-rhamnoside</td><td><italic>Camellia sinensis</italic></td><td>Flavonoid</td><td>Reduction in the number of inflammatory cells and Th2 cytokines</td><td>[<xref rid="bb0085" ref-type="bibr">17</xref>]</td></tr><tr><td>L-Theanine</td><td><italic>Camellia sinensis</italic></td><td>Amino acid</td><td>NF-&#x003ba;B and MMP-9 levels are reduced leading to anti-inflammatory activity</td><td>[<xref rid="bb0165" ref-type="bibr">33</xref>]</td></tr><tr><td>Luteolin</td><td><italic>Perilla frutescens</italic></td><td>Flavonoid</td><td>Airway mucus accumulation is inhibited by inhibition of GABAergic system</td><td>[<xref rid="bb0400" ref-type="bibr">80</xref>]</td></tr><tr><td>Mangosteen</td><td><italic>Garcinia mangostana</italic></td><td>Xanthone</td><td>Inhibition of cytokine production and histamine release</td><td>[<xref rid="bb0175" ref-type="bibr">35</xref>]</td></tr><tr><td>Naringin</td><td><italic>Citrus paradisi</italic></td><td>Flavone</td><td>Induction of calcium signalling leading to bronchoconstriction inhibition</td><td>[<xref rid="bb0490" ref-type="bibr">98</xref>]</td></tr><tr><td>Oxymatrine</td><td><italic>Sophora flavescens</italic></td><td>Alkaloid</td><td>Anti-asthmatic effect by regulation of CD-40 signalling</td><td>[<xref rid="bb0525" ref-type="bibr">105</xref>]</td></tr><tr><td>Piperine</td><td><italic>Piper nigrum</italic></td><td>Alkaloid</td><td>Inhibition of Th2 and mast cell hyperactivity</td><td>[<xref rid="bb0045" ref-type="bibr">9</xref>]</td></tr><tr><td colspan="5">&#x02028;&#x02028;</td></tr><tr><td colspan="5">Antipyretic compounds</td></tr><tr><td>Acacetin</td><td><italic>Potentilla evestita</italic></td><td>Flavone</td><td>Probably inhibits activity of prostaglandins</td><td>[<xref rid="bb0360" ref-type="bibr">72</xref>]</td></tr><tr><td>Viscosine</td><td><italic>Dodonaea viscosa</italic></td><td>Flavonoid</td><td>Inhibition of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1)</td><td>[<xref rid="bb0305" ref-type="bibr">61</xref>]</td></tr><tr><td>16-hydroxy betulinic acid</td><td><italic>Mikania cordata</italic></td><td>Triterpenoid</td><td>Unknown</td><td>[<xref rid="bb0420" ref-type="bibr">84</xref>]</td></tr><tr><td>6-(3-carboxybut-2-enyl)-7-hydroxycoumarin</td><td><italic>Peucedanum ostruthium</italic></td><td>Flavonoid</td><td>Inhibitor of cyclooxygenase and 5-lipoxygenase activity involved in prostaglandin synthesis</td><td>[<xref rid="bb0145" ref-type="bibr">29</xref>]</td></tr><tr><td>Linarin</td><td><italic>Buddleia cordata</italic></td><td>Flavonoid</td><td>Unknown</td><td>[<xref rid="bb0290" ref-type="bibr">58</xref>]</td></tr><tr><td>6-methoxy-7-hydroxy-&#x003b1;-dunnione</td><td><italic>Sinningia canescens</italic></td><td>Napthaquinone</td><td>Reduction in lipopolysaccharide-induced fever</td><td>[<xref rid="bb0265" ref-type="bibr">53</xref>]</td></tr><tr><td>Mangiferin</td><td><italic>Mangifera indica</italic></td><td>Xanthone</td><td>Synthesis of TNF-&#x003b1; is inhibited which acts as a pyrogen</td><td>[<xref rid="bb0425" ref-type="bibr">85</xref>]</td></tr><tr><td>2-hydroxy-1,4-naphthaquinone</td><td><italic>Lawsonia inermis</italic></td><td>Napthaquinone</td><td>Unknown</td><td>[<xref rid="bb0010" ref-type="bibr">2</xref>]</td></tr><tr><td>Usnic Acid and Diffractaic Acid</td><td><italic>Usnea diffracta</italic></td><td>Dibenzofuran and</td><td>Unknown</td><td>[<xref rid="bb0320" ref-type="bibr">64</xref>]</td></tr><tr><td>Artemisinin</td><td><italic>Artemisia annua</italic></td><td>Sesquiterpene</td><td>Unknown</td><td>[<xref rid="bb0315" ref-type="bibr">63</xref>]</td></tr><tr><td>Neochlorogenic Acid</td><td><italic>Hibiscus sabdariffa</italic></td><td>Polyphenol</td><td>Inhibition of lipopolysaccharide-induced fever in BV2 microglial cells</td><td>[<xref rid="bb0205" ref-type="bibr">41</xref>]</td></tr><tr><td>Phenacetin</td><td><italic>Bursera grandifolia</italic></td><td>Acetamide</td><td>Unknown</td><td>[<xref rid="bb0455" ref-type="bibr">91</xref>]</td></tr><tr><td colspan="5">&#x02028;&#x02028;</td></tr><tr><td colspan="5">Analgesic compounds</td></tr><tr><td>Aspirin</td><td><italic>Spiraea ulmaria</italic></td><td>Acetylsalicyclic acid</td><td>Inhibitor of cyclooxygenase 1 and cyclooxygenase 2</td><td>[<xref rid="bb0450" ref-type="bibr">90</xref>]</td></tr><tr><td>Morphine</td><td><italic>Papaver somniferum</italic></td><td>Opiate alkaloid</td><td>Analgesic effect by binding to mu opoid receptors present in the central and peripheral nervous system cells</td><td>[<xref rid="bb0240" ref-type="bibr">48</xref>]</td></tr><tr><td>Codeine</td><td><italic>Papaver somniferum</italic></td><td>Opiate alkaloid</td><td>Similar mode of action to morphine. Codeine is metabolised to morphine in animal body.</td><td>[<xref rid="bb0040" ref-type="bibr">8</xref>]</td></tr><tr><td>Thebaine</td><td><italic>Papaver somniferum</italic></td><td>Opiate alkaloid</td><td>Similar mode of action to morphine. Codeine is metabolised to morphine in animal body.</td><td>[<xref rid="bb0210" ref-type="bibr">42</xref>]</td></tr><tr><td>Salvinorin A</td><td><italic>Salvia divinorum</italic></td><td>Diterpenoid</td><td>Binds to kappa opoid receptors present in central and peripheral nervous system leading to analgesic effect</td><td>[<xref rid="bb0340" ref-type="bibr">68</xref>]</td></tr><tr><td>Menthol</td><td><italic>Mentha spicata</italic></td><td>Terpene</td><td>Binds to kappa opoid receptors present in central and peripheral nervous system leading to analgesic effect</td><td>[<xref rid="bb0115" ref-type="bibr">23</xref>]</td></tr><tr><td>Pawhuskin A</td><td><italic>Dalea purpurea</italic></td><td>Stillbene</td><td>Acts as opoid antagonist and binds selectively to kappa receptors</td><td>[<xref rid="bb0140" ref-type="bibr">28</xref>]</td></tr><tr><td>Cocaine</td><td><italic>Erythroxylum coca</italic></td><td>Tropane alkaloid</td><td>Acts supraspinally in a dopamine mediated and non-opiate manner to produce analgesic effect</td><td>[<xref rid="bb0250" ref-type="bibr">50</xref>]</td></tr><tr><td>Tetrahydrocannabinol</td><td><italic>Cannabis sativa</italic></td><td>Cannabinoid</td><td>Analgesia by inhibition of release of neurotransmitters and neuropeptides from nerve endings.</td><td>[<xref rid="bb0465" ref-type="bibr">93</xref>]</td></tr><tr><td colspan="5">&#x02028;&#x02028;</td></tr><tr><td colspan="5">Bronchodilation compounds</td></tr><tr><td>Emodin</td><td><italic>Folium Sennae</italic></td><td>Anthraquinone</td><td>Inhibition of acetylcholine mediated contraction of airway smooth muscle</td><td>[<xref rid="bb0355" ref-type="bibr">71</xref>]</td></tr><tr><td>Curcumin</td><td><italic>Curcuma longa</italic></td><td>Polyphenol</td><td>Relaxation of tracheal smooth muscles contraction mediated by KCl. Regulation involves calcium channel blocking and potassium channel opening</td><td>[<xref rid="bb0110" ref-type="bibr">22</xref>]</td></tr><tr><td>Berberine</td><td><italic>Berberis aristata</italic></td><td>Alkaloid</td><td>Inhibition of histamine receptors, cyclooxygenase pathway and nitric oxide which are involved in bronchoconstriction</td><td>[<xref rid="bb0375" ref-type="bibr">75</xref>]</td></tr><tr><td>9-octadecenamide</td><td><italic>Anacardium occidentale</italic></td><td>Amide derivative of fatty acid</td><td>Inhibition of histamine mediated bronchoconstriction</td><td>[<xref rid="bb0025" ref-type="bibr">5</xref>]</td></tr><tr><td>Cyclomicrobuxine and its derivatives</td><td><italic>Buxus papillosa</italic></td><td>Steroidal alkaloids</td><td>Inhibition of calcium channels involved in bronchoconstriction</td><td>[<xref rid="bb0190" ref-type="bibr">38</xref>]</td></tr><tr><td>Citral</td><td><italic>Zingiber officinale</italic></td><td>Terpenoid</td><td>Bronchodialation by regulation of &#x003b2;-adrenergic receptor</td><td>[<xref rid="bb0285" ref-type="bibr">57</xref>]</td></tr><tr><td colspan="5">&#x02028;&#x02028;</td></tr><tr><td colspan="5">Expectorant compounds</td></tr><tr><td>chlorogenic acid, 3,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid</td><td><italic>Tussilago farfara</italic></td><td>Caffeoylquinic acids</td><td>Unknown</td><td>[<xref rid="bb0500" ref-type="bibr">100</xref>]</td></tr><tr><td>Liquiritin apioside, liquiritigenin and liquiritin</td><td><italic>Glycyrrhiza uralensis</italic></td><td>Flavonoid</td><td>Unknown</td><td>[<xref rid="bb0220" ref-type="bibr">44</xref>]</td></tr><tr><td>Caffeoylquinic acids, astersaponins, and aster peptides</td><td><italic>Aster tataricus</italic></td><td>Caffeoylquinic acid, saponin and peptide</td><td>Unknown</td><td>[<xref rid="bb0515" ref-type="bibr">103</xref>]</td></tr><tr><td>Imperialine, imperialine-&#x003b2;-N-oxide, isoverticine, and isoverticine-&#x003b2;-N-oxide</td><td><italic>Fritillaria wabuensis</italic></td><td>Alkaloids</td><td>Unknown</td><td>[<xref rid="bb0470" ref-type="bibr">94</xref>]</td></tr><tr><td>imperialine, chuanbeinone, verticinone and verticine</td><td><italic>Fritillariae cirrhosae</italic></td><td>Alkaloids</td><td>Unknown</td><td>[<xref rid="bb0475" ref-type="bibr">95</xref>]</td></tr><tr><td>Vasicine, deoxyvasicine and vasicinone</td><td><italic>Peganum harmala</italic></td><td>Quinazoline alkaloids</td><td>Unknown</td><td>[<xref rid="bb0260" ref-type="bibr">52</xref>]</td></tr></tbody></table></table-wrap></p></sec><sec id="s0015"><label>3</label><title>Identification of novel therapeutic biomolecules in plants</title><p id="p0045">Plants could serve as a reservoir of potential drugs and therapeutic molecules, and an integrated approach is required to identify and characterize those molecules. Proteomic and metabolomic profiling using high-throughput platforms are a boon for large-scale analysis of plant extracts to identify the biomolecular composition of those extracts. A comprehensive review of literature that exists in use within the community or population can help to identify the potential plants that can be targeted for metabolic screening. Predominantly, metabolites possess therapeutic properties than the simple protein molecules which are reported to be involved in cellular and biological processes of plants. Sampling of plants at different stages of development, preparation of tissue-specific extracts (using different solvents), and analysis of those extracts using Gas and/or Liquid Chromatography-Mass spectrometry can identify metabolites and other volatile compounds present in the extract. High-Performance Thin-Layer Chromatography can assist in fingerprinting of secondary metabolites and separating those metabolites at high-resolution. Computational tools coupled with these platforms, aid in the identification of the metabolites, whose chemical structure can be resolved at high-resolution using several available <italic>in silico</italic> approaches. For screening the efficacy of these biomolecules and studying the potent inhibitors against coronavirus, computer-aided drug design (CADD) serves as a reliable approach [<xref rid="bb0480" ref-type="bibr">96</xref>,<xref rid="bb0535" ref-type="bibr">107</xref>] as it facilitates a multidimensional study of molecular interactions between putative anti-COVID-19 compounds and target proteins. This approach has suggested the interaction of SARS-CoV-2 encoded proteins with different phytochemicals. 3C-like protease (3CL<sup>pro</sup>), also known as Main protease (M<sup>pro</sup>) is an attractive target for anti-CoV drug design. It is a cysteine protease and is responsible for cleaving the replicase polypeptide into various functional proteins and essential for virus multiplication. Phenolic compounds such as coumarin, flavones [<xref rid="bb0195" ref-type="bibr">39</xref>], baicalin, cyanidin 3-glucoside, and &#x003b1;-ketoamide-11r [<xref rid="bb0170" ref-type="bibr">34</xref>] have structural similarity with the protease and might be the potential and safer inhibitors against the SARS-CoV-2. Apart from this, the Moroccan Medicinal plants containing Crocin, Digitoxigenin, and &#x003b2;-Eudesmol were projected as COVID-19 inhibitors based on the computational investigation with a benefit of oral intake [<xref rid="bb0005" ref-type="bibr">1</xref>]. Phytochemicals such as Belachinal, Macaflavanone E, and Vibsanol B have been found to restrict the formation of ion channels by oligomerization of &#x02018;SARS-CoV2 E', thus inhibiting the virus pathogenesis [<xref rid="bb0125" ref-type="bibr">25</xref>].</p><p id="p0050">The interaction between Spike (S) Glycoprotein of SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) receptor is crucial for the entry of SARS-CoV-2 into the human alveolar epithelial cells. Different plant-derived lectins such as Griffithsin and <italic>Urtica dioica</italic> agglutinin lectin interact with S protein and inhibit the binding onto the host cell [<xref rid="bb0225" ref-type="bibr">45</xref>,<xref rid="bb0295" ref-type="bibr">59</xref>]. Simultaneously, phytoestrogens, especially Diadiazin, Genistein, Formontein, and Biochanin A were found to have a high affinity towards the substrate-binding domain &#x003b2; (SBD&#x003b2;) of Heat Shock Protein A5 (HSPA5). It is the host-cell receptor that interacts with S protein of COVID-19 and leads to the entry of the pathogen into the host cell. These phytoestrogens have been reported to act as competitive inhibitors against Spike protein by binding onto the active site of HSPA5 [<xref rid="bb0105" ref-type="bibr">21</xref>]. Recently, <italic>Withania somnifera</italic> compound, Withanone (Wi-N) was found to weaken the binding between ACE2-RBD complex and was thus proposed to control the virus entry into the host cell [<xref rid="bb0035" ref-type="bibr">7</xref>]. Kumar et al. [<xref rid="bb0230" ref-type="bibr">46</xref>] had also shown that Wi-N and caffeic acid phenethyl ester of <italic>W. somnifera</italic> interact with the highly conserved protease, M<sup>pro</sup> of SARS-CoV-2. These reports justify that plant-based anti-COVID drugs could save time and cost for designing/developing new therapeutic molecules; however, large-scale screening of plants for identifying such potential biomolecules is imperative. Such compounds once identified will be processed to the further steps for laboratory trials and clinical trials followed by large-scale production, purification, and application at the end-user level.</p></sec><sec id="s0020"><label>4</label><title>Genetics and genomics approaches for the production of therapeutic biomolecules</title><sec id="s0025"><label>4.1</label><title>Forward and reverse genetics approaches</title><p id="p0055">Plant biotechnology offers a broad spectrum of production strategies at different levels, including whole plant, tissue, and cell. Hairy roots and cell suspension cultures facilitate the synthesis of biomolecules at large-scale [<xref rid="bb0130" ref-type="bibr">26</xref>]. In addition, advances in genetics and genomics had also facilitated the manipulation of genes and pathways underlying the biosynthesis of therapeutic molecules. Numerous approaches for genetic manipulation of genes and genomes are available in plants, including stable transformation (transgenics and transplastomics), transient and inducible expression systems, gene silencing approaches (knockdown and knockout), and genome editing methods. A transient expression for vaccine production is beneficial over stable transgenics as it saves time and expedites the large-scale manufacturing in pandemic situations. <xref rid="f0010" ref-type="fig">Fig. 2</xref>
illustrates how genomics and biotechnology could intervene in producing plant-based drugs. Next-generation sequencing provides comprehensive information about the genes, non-coding regions, and regulatory elements present in the genome, which enables rapid identification of the genes involved in the biosynthesis of therapeutic molecules. Forward genetics approach of estimating the biomolecule content (or large-scale metabolite profiling) in a given population followed by genotyping (genotyping-by-sequencing, double digest restriction-site associated DNA sequencing, whole-genome resequencing, <italic>etc.</italic>) will identify the genomic regions regulating the biosynthesis of individual molecules. These genomic regions (genes/alleles/QTLs) can be effectually used in genomics-assisted breeding for developing elite lines producing higher levels of target molecules. On the other hand, gene cloning enables the isolation and molecular characterization of target genes encoding for active biomolecules that can be transformed into a different plant system (<italic>Nicotiana,</italic> for example, is a widely used system for plant-based drugs) for the ease of expression, optimization of production and purification. For instance, <italic>N. benthamiana</italic> is now being used as an efficient system for expressing VLP of SARS-CoV-2 to produce a plant-based vaccine. Similarly, these heterologous systems can be used to produce the desired biomolecules that could be isolated and purified for further downstream approaches. A few metabolites could be tissue- or development-specific, and therefore, finetuning their expression throughout the life cycle of the respective plant is imperative to ensure a maximum harvest. For example, &#x003b2;&#x02013;Eudesmol has been found to have antibacterial and antiviral properties; however, its usage as an antiviral drug is limited due to its low level (2.39%) of production in <italic>Lauris nobilis</italic> [<xref rid="bb0020" ref-type="bibr">4</xref>]. Promoter cloning or manipulation of <italic>cis-</italic>regulatory elements in the promoter regions could provide an amenable solution to this issue. CRISPR/Cas9 approach can be deployed to edit the <italic>cis-</italic>elements present upstream to the gene(s) for ensuring its expression throughout the life cycle of the target plant. Genetic elements regulating post-translational events acting on the therapeutic biomolecule of interest should also be studied.<fig id="f0010"><label>Fig. 2</label><caption><p>Different approaches for using plant-based biomolecules against SARS-CoV-2. Plants are a store house of active metabolites, and identification of these metabolites through targeted and untargeted metabolomics is important. These metabolites can be tested for their antiviral activity and released for treating viral diseases. On the other hand, plant based edible vaccines can be synthesized by expressing viral epitopes in plants. These vaccines are easy to store and propagate. (Image created using <ext-link ext-link-type="uri" xlink:href="http://freepik.com" id="ir0005">freepik.com</ext-link>).</p></caption><alt-text id="al0010">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p></sec><sec id="s0030"><label>4.2</label><title>Genome editing and overexpression systems</title><p id="p0060">CRISPR/Cas9 method enables precise editing of genes, particularly this applies to knock out the enzymes that utilize the target biomolecule as a precursor for further processing and to facilitate rate-limiting processes for over-production of desired metabolites. Transient approaches, including RNA interference or virus-induced gene silencing, could also assist in finetuning the biosynthetic machinery to achieve a higher level of production. Stable transformation of genes and overexpression in the plant system could be achieved through several approaches existing for genetic transformation. <italic>Agrobacterium-</italic>mediated transformation is one such reliable approach where the gene of interest is cloned into the Ti-plasmid and transferred to a plant for integration into the genome [<xref rid="bb0280" ref-type="bibr">56</xref>]. This approach has been widely used in crop improvement for stress tolerance and agronomic traits. Given the broader application, this could be easily adapted for producing target biomolecules in diverse plant systems, where further downstream processing and purification is easy and straightforward. For instance, extracts of Chinese medicinal plants, <italic>Panax ginseng</italic> and <italic>Magnolia officinalis</italic> have anti-inflammatory properties, but since they are endangered species, their use in therapeutics is restricted. In such a case, studying the biosynthetic pathways and engineering them into a model plant species such as maize, tomato, rice, and tobacco reduces the pressure on parent medicinal plants [<xref rid="bb0300" ref-type="bibr">60</xref>] and provides the key to achieve production of beneficial compounds. Some natural compounds may require chemical modifications to increase their potency so that they can be used as a therapeutic drug. For example, a naturally occurring saponin, glycyrrhizin, was found to inhibit the replication of coronavirus, but modifying its glycoside chain enhances the antiviral activity by ten folds [<xref rid="bb0150" ref-type="bibr">30</xref>]. Similarly, increased antiviral activity was observed for tomentins and quercetin-7-rhamnoside as compared to their non-modified precursors [<xref rid="bb0065" ref-type="bibr">13</xref>,<xref rid="bb0070" ref-type="bibr">14</xref>]. These reports accentuate that biotechnology can also bridge the gap between the identification of naturally derived compound(s) and their usage as the therapeutic drug with a reduced timeline and increased efficacy. Also, the administration of plant-based drugs either through topical application or oral intake reduces the stringencies associated with ultra-high purification and storage issues. This will simultaneously reduce manufacturing as well as downstream processing costs.</p></sec></sec><sec id="s0035"><label>5</label><title>Conclusions and future perspectives</title><p id="p0065">Plants are primarily under-studied for their use in therapeutic purposes for treating infectious diseases; however, the traditional medicines have taken complete advantage of the entire plant kingdom. The gap between conventional treatment using herbs and extracts and the knowledge on the bioactive compounds present in those plant extracts, as well as their mode of action leading to disease recovery, needs to be bridged. Advances in science and advent of next-generation scientific research and discovery had delivered several tools, techniques, approaches, and strategies that can be effectually used in dissecting the metabolomic profile of plant species to identify the potential compounds that could possess anti-SARS-CoV-2 activities. Computational methods, including molecular modeling, docking, structure analysis, <italic>etc.</italic> can assist in performing experiments and validation of results virtually before undertaking further <italic>in vitro</italic> and <italic>in vivo</italic> studies<italic>.</italic> The intervention of genomics and biotechnological approaches to modulate the genes underlying biosynthesis and accumulation of these therapeutic biomolecules gains importance in the current scenario (<xref rid="f0015" ref-type="fig">Fig. 3</xref>
). The identification of unique compounds present in plants may be laborious, but once identified, screening the compounds for therapeutic applications in treating COVID-19 infected patients, devising appropriate strategies for optimized production and purification of such compounds, and pursuing further validation studies in the laboratory and clinical trials may be expedited keeping in view the eco-friendliness and safety aspects of plant-based drugs. Also, the availability of a repository of plant-based therapeutic biomolecules will play an important role in confronting future health emergencies.<fig id="f0015"><label>Fig. 3</label><caption><p>Schematic representation of biotechnology and omics-based strategies for profiling and application of plant-based antiviral phytochemicals against COVID-19. It includes identification of the plant encoding the active molecule, purification and evaluation for its role against SARS-CoV2. The Omics-based approach helps in recognition of different biological components associated with the pathway of phytochemical synthesis. Initially, Genomic approach is used to detect the gene coding for the active molecule. This information can be used to identify the homologous genes from other plant species and for functional characterization of the gene. The transcriptomic and proteomic approach depicts the active pathways in the plant associated with the molecule production. The metabolomic approach is the primary tool for detecting the main bioactive compound and the biosynthetic pathway regulating its synthesis in the plant. The metabolite or protein identified by integration of these approaches is studied for its role against SARS-CoV2. This is achieved either by computational/bioinformatics-based docking between the active compound and virus encoded proteins followed by clinical trials or by purification of the phytochemical through chromatography followed by its clinical trial. Further, by applying biotechnology the concentration of these metabolites can be increased significantly. It includes developing stable transformations in plants or by expressing the synthesis machinery into a heterologous system or using transformed root cultures or through chemical modifications in the active molecule to increase its potency as an antiviral compound.</p></caption><alt-text id="al0015">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig></p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="p0075">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Aanouz</surname><given-names>I.</given-names></name><name><surname>Belhassan</surname><given-names>A.</given-names></name><name><surname>El-Khatabi</surname><given-names>K.</given-names></name><name><surname>Lakhlifi</surname><given-names>T.</given-names></name><name><surname>El-Ldrissi</surname><given-names>M.</given-names></name><name><surname>Bouachrine</surname><given-names>M.</given-names></name></person-group><article-title>Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations</article-title><source>J. Biomol. Struct. Dyn.</source><volume>2020</volume><year>2020</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>B.H.</given-names></name><name><surname>Bashir</surname><given-names>A.K.</given-names></name><name><surname>Tanira</surname><given-names>M.O.M.</given-names></name></person-group><article-title>Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats</article-title><source>Pharmacology</source><volume>51</volume><year>1995</year><fpage>356</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">8966192</pub-id></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name><surname>Asres</surname><given-names>K.</given-names></name><name><surname>Bucar</surname><given-names>F.</given-names></name></person-group><article-title>Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle</article-title><source>Ethiop. Med. J.</source><volume>43</volume><year>2005</year><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16370525</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name><surname>Astani</surname><given-names>A.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Schnitzler</surname><given-names>P.</given-names></name></person-group><article-title>Screening for antiviral activities of isolated compounds from essential oils</article-title><source>Evid. Based Complement. Altern. Med.</source><volume>2011</volume><year>2011</year><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name><surname>Awakan</surname><given-names>O.J.</given-names></name><name><surname>Malomo</surname><given-names>S.O.</given-names></name><name><surname>Adejare</surname><given-names>A.A.</given-names></name><name><surname>Igunnu</surname><given-names>A.</given-names></name><name><surname>Atolani</surname><given-names>O.</given-names></name><name><surname>Adebayo</surname><given-names>A.H.</given-names></name><name><surname>Owoyele</surname><given-names>B.V.</given-names></name></person-group><article-title>Anti-inflammatory and bronchodilatory constituents of leaf extracts of Anacardium occidentale L. in animal models</article-title><source>J. Integr. Med.</source><volume>16</volume><year>2018</year><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">29397096</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name></person-group><article-title>Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-&#x003ba;B</article-title><source>Toxicol. Appl. Pharmacol.</source><volume>254</volume><year>2011</year><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">21515303</pub-id></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name><surname>Balkrishna</surname><given-names>A.</given-names></name><name><surname>Pokhrel</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Varshney</surname><given-names>A.</given-names></name></person-group><article-title>Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor</article-title><source>Res. Sq.</source><year>2020</year><pub-id pub-id-type="doi">10.21203/rs.3.rs-17806/v1</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name><surname>Bhandari</surname><given-names>M.</given-names></name><name><surname>Bhandari</surname><given-names>A.</given-names></name><name><surname>Bhandari</surname><given-names>A.</given-names></name></person-group><article-title>Recent updates on codeine</article-title><source>Pharm. Methods</source><volume>2</volume><year>2011</year><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23781422</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>T.T.</given-names></name><name><surname>Piao</surname><given-names>C.H.</given-names></name><name><surname>Song</surname><given-names>C.H.</given-names></name><name><surname>Shin</surname><given-names>H.S.</given-names></name><name><surname>Shon</surname><given-names>D.H.</given-names></name><name><surname>Chai</surname><given-names>O.H.</given-names></name></person-group><article-title>Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation</article-title><source>Cell. Immunol.</source><volume>322</volume><year>2017</year><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">29066080</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name><surname>Capell</surname><given-names>T.</given-names></name><name><surname>Twyman</surname><given-names>R.M.</given-names></name><name><surname>Armario-Najera</surname><given-names>V.</given-names></name><name><surname>Ma</surname><given-names>J.K.</given-names></name><name><surname>Schillberg</surname><given-names>S.</given-names></name><name><surname>Christou</surname><given-names>P.</given-names></name></person-group><article-title>Potential applications of plant biotechnology against SARS-CoV-2</article-title><source>Trends Plant Sci.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.tplants.2020.04.009</pub-id></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name><surname>Chantrill</surname><given-names>B.H.</given-names></name><name><surname>Coulthard</surname><given-names>C.E.</given-names></name><name><surname>Dickinson</surname><given-names>L.</given-names></name><name><surname>Inkley</surname><given-names>G.W.</given-names></name><name><surname>Morris</surname><given-names>W.</given-names></name><name><surname>Pyle</surname><given-names>A.H.</given-names></name></person-group><article-title>The action of plant extracts on a bacteriophage of Pseudomonas pyocyanea and on influenza a virus</article-title><source>J. Gen. Microbiol.</source><volume>6</volume><year>1952</year><fpage>74</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">14927853</pub-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.N.</given-names></name><name><surname>Lin</surname><given-names>C.P.</given-names></name><name><surname>Huang</surname><given-names>K.K.</given-names></name><name><surname>Chen</surname><given-names>W.C.</given-names></name><name><surname>Hsieh</surname><given-names>H.P.</given-names></name><name><surname>Liang</surname><given-names>P.H.</given-names></name><name><surname>Hsu</surname><given-names>J.T.</given-names></name></person-group><article-title>Inhibition of SARS-CoV 3C-like protease activity by Theaflavin-3,3&#x02032;-digallate (TF3)</article-title><source>Evid. Based Complement. Altern. Med.</source><volume>2</volume><year>2005</year><fpage>209</fpage><lpage>215</lpage></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.K.</given-names></name><name><surname>Curtis-Long</surname><given-names>M.J.</given-names></name><name><surname>Lee</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>D.W.</given-names></name><name><surname>Ryu</surname><given-names>H.W.</given-names></name><name><surname>Yuk</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name></person-group><article-title>Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of <italic>Paulownia tomentosa</italic></article-title><source>Bioorg. Med. Chem.</source><volume>21</volume><year>2013</year><fpage>3051</fpage><lpage>3057</lpage><pub-id pub-id-type="pmid">23623680</pub-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name><name><surname>Ahn</surname><given-names>Y.J.</given-names></name><name><surname>Song</surname><given-names>J.H.</given-names></name><name><surname>Baek</surname><given-names>S.H.</given-names></name><name><surname>Kwon</surname><given-names>D.H.</given-names></name></person-group><article-title>Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus</article-title><source>Antivir. Res.</source><volume>81</volume><year>2009</year><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">18992773</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Nie</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group><article-title>Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1&#x02013;GATA3 signaling pathway</article-title><source>Inflammation</source><volume>37</volume><year>2014</year><fpage>1476</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">24706026</pub-id></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>K.T.</given-names></name><name><surname>Wong</surname><given-names>A.Y.L.</given-names></name><name><surname>Kaewpreedee</surname><given-names>P.</given-names></name><name><surname>Sia</surname><given-names>S.F.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Hui</surname><given-names>K.P.Y.</given-names></name><name><surname>Chu</surname><given-names>D.K.W.</given-names></name><name><surname>Chan</surname><given-names>M.C.W.</given-names></name><name><surname>Cheung</surname><given-names>P.P.H.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Peiris</surname><given-names>M.</given-names></name></person-group><article-title>Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro</article-title><source>Antivir. Res.</source><volume>178</volume><year>2020</year><comment>(104786&#x02013;104786)</comment></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>M.J.</given-names></name><name><surname>Pandey</surname><given-names>R.P.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name><name><surname>Sohng</surname><given-names>J.K.</given-names></name><name><surname>Choi</surname><given-names>D.J.</given-names></name><name><surname>Park</surname><given-names>Y. Il</given-names></name></person-group><article-title>Inhibitory effects of kaempferol-3-O-rhamnoside on ovalbumin-induced lung inflammation in a mouse model of allergic asthma</article-title><source>Int. Immunopharmacol.</source><volume>25</volume><year>2015</year><fpage>302</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">25698556</pub-id></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>S.</given-names></name><name><surname>Scaccabarozzi</surname><given-names>D.</given-names></name><name><surname>Signorini</surname><given-names>L.</given-names></name><name><surname>Perego</surname><given-names>F.</given-names></name><name><surname>Ilboudo</surname><given-names>D.P.</given-names></name><name><surname>Ferrante</surname><given-names>P.</given-names></name><name><surname>Delbue</surname><given-names>S.</given-names></name></person-group><article-title>The use of antimalarial drugs against viral infection</article-title><source>Microorganisms</source><volume>8</volume><year>2020</year><fpage>85</fpage></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name><surname>Debiaggi</surname><given-names>M.</given-names></name><name><surname>Pagani</surname><given-names>L.</given-names></name><name><surname>Cereda</surname><given-names>P.M.</given-names></name><name><surname>Landini</surname><given-names>P.</given-names></name><name><surname>Romero</surname><given-names>E.</given-names></name></person-group><article-title>Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2</article-title><source>Microbiologica</source><volume>11</volume><year>1988</year><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">2832710</pub-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name></person-group><article-title>Crocetin activates Foxp3 through TIPE2 in asthma-associated treg cells</article-title><source>Cell. Physiol. Biochem.</source><volume>37</volume><year>2015</year><fpage>2425</fpage><lpage>2433</lpage><pub-id pub-id-type="pmid">26646898</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name><surname>Elfiky</surname><given-names>A.A.</given-names></name></person-group><article-title>Natural products may interfere with SARS-CoV-2 attachment to the host cell</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1761881</pub-id></element-citation></ref><ref id="bb0110"><label>22</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name><surname>Emami</surname><given-names>B.</given-names></name><name><surname>Shakeri</surname><given-names>F.</given-names></name><name><surname>Gholamnezhad</surname><given-names>Z.</given-names></name><name><surname>Saadat</surname><given-names>S.</given-names></name><name><surname>Boskabady</surname><given-names>M.</given-names></name><name><surname>Azmounfar</surname><given-names>V.</given-names></name><name><surname>Sadatfaraji</surname><given-names>H.</given-names></name><name><surname>Boskabady</surname><given-names>M.H.</given-names></name></person-group><article-title>Calcium and potassium channels are involved in curcumin relaxant effect on tracheal smooth muscles</article-title><source>Pharm. Biol.</source><volume>58</volume><year>2020</year><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">32208946</pub-id></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name><surname>Galeotti</surname><given-names>N.</given-names></name><name><surname>Di Cesare Mannelli</surname><given-names>L.</given-names></name><name><surname>Mazzanti</surname><given-names>G.</given-names></name><name><surname>Bartolini</surname><given-names>A.</given-names></name><name><surname>Ghelardini</surname><given-names>C.</given-names></name></person-group><article-title>Menthol: a natural analgesic compound</article-title><source>Neurosci. Lett.</source><volume>322</volume><year>2002</year><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">11897159</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name><surname>Greiner</surname><given-names>J.F.W.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>J.</given-names></name><name><surname>Zeuner</surname><given-names>M.T.</given-names></name><name><surname>Hauser</surname><given-names>S.</given-names></name><name><surname>Seidel</surname><given-names>T.</given-names></name><name><surname>Klenke</surname><given-names>C.</given-names></name><name><surname>Grunwald</surname><given-names>L.M.</given-names></name><name><surname>Schomann</surname><given-names>T.</given-names></name><name><surname>Widera</surname><given-names>D.</given-names></name><name><surname>Sudhoff</surname><given-names>H.</given-names></name><name><surname>Kaltschmidt</surname><given-names>B.</given-names></name><name><surname>Kaltschmidt</surname><given-names>C.</given-names></name></person-group><article-title>1,8-cineol inhibits nuclear translocation of NF-&#x003ba;B p65 and NF-&#x003ba;B-dependent transcriptional activity</article-title><source>Biochim. Biophys. Acta, Mol. Cell Res.</source><volume>1833</volume><year>2013</year><fpage>2866</fpage><lpage>2878</lpage></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>M.K.</given-names></name><name><surname>Vemula</surname><given-names>S.</given-names></name><name><surname>Donde</surname><given-names>R.</given-names></name><name><surname>Gouda</surname><given-names>G.</given-names></name><name><surname>Behera</surname><given-names>L.</given-names></name><name><surname>Vadde</surname><given-names>R.</given-names></name></person-group><article-title>In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1751300</pub-id></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name><surname>Gutierrez-Valdes</surname><given-names>N.</given-names></name><name><surname>H&#x000e4;kkinen</surname><given-names>S.T.</given-names></name><name><surname>Lemasson</surname><given-names>C.</given-names></name><name><surname>Guillet</surname><given-names>M.</given-names></name><name><surname>Oksman-Caldentey</surname><given-names>K.M.</given-names></name><name><surname>Ritala</surname><given-names>A.</given-names></name><name><surname>Cardon</surname><given-names>F.</given-names></name></person-group><article-title>Hairy root cultures-A versatile tool with multiple applications</article-title><source>Front. Plant Sci.</source><volume>3</volume><issue>11</issue><year>2020</year><fpage>33</fpage></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>F.</given-names></name><name><surname>Fr&#x000f6;hlich</surname><given-names>T.</given-names></name><name><surname>Frank</surname><given-names>T.</given-names></name><name><surname>Bertzbach</surname><given-names>L.D.</given-names></name><name><surname>Kohrt</surname><given-names>S.</given-names></name><name><surname>Kaufer</surname><given-names>B.B.</given-names></name><name><surname>Stamminger</surname><given-names>T.</given-names></name><name><surname>Tsogoeva</surname><given-names>S.B.</given-names></name><name><surname>Marschall</surname><given-names>M.</given-names></name></person-group><article-title>Artesunate-derived monomeric, dimeric and trimeric experimental drugs - their unique mechanistic basis and pronounced antiherpesviral activity</article-title><source>Antivir. Res.</source><volume>152</volume><year>2018</year><fpage>104</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">29458133</pub-id></element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name><surname>Hartung</surname><given-names>A.M.</given-names></name><name><surname>Beutler</surname><given-names>J.A.</given-names></name><name><surname>Navarro</surname><given-names>H.A.</given-names></name><name><surname>Wiemer</surname><given-names>D.F.</given-names></name><name><surname>Neighbors</surname><given-names>J.D.</given-names></name></person-group><article-title>Stilbenes as &#x003ba;-selective, non-nitrogenous opioid receptor antagonists</article-title><source>J. Nat. Prod.</source><volume>77</volume><year>2014</year><fpage>311</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">24456556</pub-id></element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name><surname>Hiermann</surname><given-names>A.</given-names></name><name><surname>Schantl</surname><given-names>D.</given-names></name></person-group><article-title>Antiphlogistic and antipyretic activity of Peucedanum ostruthium</article-title><source>Planta Med.</source><volume>64</volume><year>1998</year><fpage>400</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">9690339</pub-id></element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name><surname>Hoever</surname><given-names>G.</given-names></name><name><surname>Baltina</surname><given-names>L.</given-names></name><name><surname>Michaelis</surname><given-names>M.</given-names></name><name><surname>Kondratenko</surname><given-names>R.</given-names></name><name><surname>Baltina</surname><given-names>L.</given-names></name><name><surname>Tolstikov</surname><given-names>G.A.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name></person-group><article-title>Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus</article-title><source>J. Med. Chem.</source><volume>48</volume><year>2005</year><fpage>1256</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">15715493</pub-id></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name><surname>Hoskins</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>J.L.</given-names></name><name><surname>Milne</surname><given-names>G.</given-names></name><name><surname>Choi</surname><given-names>L.</given-names></name><name><surname>Dworski</surname><given-names>Y.</given-names></name></person-group><article-title>Natural source d-&#x003b1;-tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo</article-title><source>Allergy</source><volume>67</volume><year>2012</year><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">22435735</pub-id></element-citation></ref><ref id="bb0160"><label>32</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>K.L.</given-names></name><name><surname>Lai</surname><given-names>Y.K.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Chang</surname><given-names>J.M.</given-names></name></person-group><article-title>Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells</article-title><source>World J. Gastroenterol.</source><volume>12</volume><year>2006</year><comment>(5721&#x02013;5721)</comment></element-citation></ref><ref id="bb0165"><label>33</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>Y.P.</given-names></name><name><surname>Jin</surname><given-names>S.W.</given-names></name><name><surname>Choi</surname><given-names>J.H.</given-names></name><name><surname>Choi</surname><given-names>C.Y.</given-names></name><name><surname>Kim</surname><given-names>H.G.</given-names></name><name><surname>Kim</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>K.J.</given-names></name><name><surname>Chung</surname><given-names>Y.C.</given-names></name><name><surname>Jeong</surname><given-names>H.G.</given-names></name></person-group><article-title>Inhibitory effects of L-theanine on airway inflammation in ovalbumin-induced allergic asthma</article-title><source>Food Chem. Toxicol.</source><volume>99</volume><year>2017</year><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">27908701</pub-id></element-citation></ref><ref id="bb0170"><label>34</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>R.</given-names></name><name><surname>Parves</surname><given-names>R.</given-names></name><name><surname>Paul</surname><given-names>A.S.</given-names></name><name><surname>Uddin</surname><given-names>N.</given-names></name><name><surname>Rahman</surname><given-names>M.S.</given-names></name><name><surname>Mamun</surname><given-names>A.A.</given-names></name><name><surname>Hossain</surname><given-names>M.N.</given-names></name><name><surname>Ali</surname><given-names>M.A.</given-names></name><name><surname>Halim</surname><given-names>M.A.</given-names></name></person-group><article-title>A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1761883</pub-id></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>H.Y.</given-names></name><name><surname>Kwon</surname><given-names>O.K.</given-names></name><name><surname>Oh</surname><given-names>S.R.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Chin</surname><given-names>Y.W.</given-names></name></person-group><article-title>Mangosteen xanthones mitigate ovalbumin-induced airway inflammation in a mouse model of asthma</article-title><source>Food Chem. Toxicol.</source><volume>50</volume><year>2012</year><fpage>4042</fpage><lpage>4050</lpage><pub-id pub-id-type="pmid">22943973</pub-id></element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.H.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name></person-group><article-title>Inhibition of SARS-CoV 3CL protease by flavonoids</article-title><source>J. Enzyme Inhib. Med. Chem.</source><volume>35</volume><year>2020</year><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">31724441</pub-id></element-citation></ref><ref id="bb0185"><label>37</label><element-citation publication-type="book" id="rf0185"><person-group person-group-type="author"><name><surname>Khaerunnisa</surname><given-names>S.</given-names></name><name><surname>Kurniawan</surname><given-names>H.</given-names></name><name><surname>Awaluddin</surname><given-names>R.</given-names></name><name><surname>Suhartati</surname><given-names>S.</given-names></name><name><surname>Soetjipto</surname><given-names>S.</given-names></name></person-group><chapter-title>Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study</chapter-title><year>2020</year><pub-id pub-id-type="doi">10.20944/preprints202003.0226.v1</pub-id></element-citation></ref><ref id="bb0190"><label>38</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A. Ullah</given-names></name><name><surname>Ali</surname><given-names>S.</given-names></name><name><surname>Gilani</surname><given-names>A.H.</given-names></name><name><surname>Ahmed</surname><given-names>M.</given-names></name><name><surname>Choudhary</surname><given-names>M.I.</given-names></name></person-group><article-title>Antispasmodic, bronchodilator, vasorelaxant and cardiosuppressant effects of Buxus papillosa</article-title><source>BMC Complement. Altern. Med.</source><volume>17</volume><year>2017</year><fpage>54</fpage><pub-id pub-id-type="pmid">28100216</pub-id></element-citation></ref><ref id="bb0195"><label>39</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S.A.</given-names></name><name><surname>Zia</surname><given-names>K.</given-names></name><name><surname>Ashraf</surname><given-names>S.</given-names></name><name><surname>Uddin</surname><given-names>R.</given-names></name><name><surname>Ul-Haq</surname><given-names>Z.</given-names></name></person-group><article-title>Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1751298</pub-id></element-citation></ref><ref id="bb0200"><label>40</label><element-citation publication-type="journal" id="rf0200"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.E.</given-names></name><name><surname>Min</surname><given-names>J.S.</given-names></name><name><surname>Jang</surname><given-names>M.S.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Shin</surname><given-names>Y.S.</given-names></name><name><surname>Park</surname><given-names>C.M.</given-names></name><name><surname>Song</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.R.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>Y.H.</given-names></name><name><surname>Kwon</surname><given-names>S.</given-names></name></person-group><article-title>Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human Lung cells</article-title><source>Biomolecules</source><volume>9</volume><year>2019</year><fpage>696</fpage></element-citation></ref><ref id="bb0205"><label>41</label><element-citation publication-type="journal" id="rf0205"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Choi</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>P.</given-names></name><name><surname>Hur</surname><given-names>J.</given-names></name></person-group><article-title>Neochlorogenic acid inhibits lipopolysaccharide-induced activation and pro-inflammatory responses in BV2 microglial cells</article-title><source>Neurochem. Res.</source><volume>40</volume><year>2015</year><fpage>1792</fpage><lpage>1798</lpage><pub-id pub-id-type="pmid">26152332</pub-id></element-citation></ref><ref id="bb0210"><label>42</label><element-citation publication-type="journal" id="rf0210"><person-group person-group-type="author"><name><surname>Kodaira</surname><given-names>H.</given-names></name><name><surname>Spector</surname><given-names>S.</given-names></name></person-group><article-title>Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>85</volume><year>1988</year><fpage>1267</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">3422490</pub-id></element-citation></ref><ref id="bb0215"><label>43</label><element-citation publication-type="journal" id="rf0215"><person-group person-group-type="author"><name><surname>Kotwal</surname><given-names>G.J.</given-names></name><name><surname>Kaczmarek</surname><given-names>J.N.</given-names></name><name><surname>Leivers</surname><given-names>S.</given-names></name><name><surname>Ghebremariam</surname><given-names>Y.T.</given-names></name><name><surname>Kulkarni</surname><given-names>A.P.</given-names></name><name><surname>Bauer</surname><given-names>G.</given-names></name><name><surname>De Beer</surname><given-names>C.</given-names></name><name><surname>Preiser</surname><given-names>W.</given-names></name><name><surname>Mohamed</surname><given-names>A.R.</given-names></name></person-group><article-title>Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral</article-title><source>Ann. N. Y. Acad. Sci.</source><volume>1056</volume><year>2005</year><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">16387696</pub-id></element-citation></ref><ref id="bb0220"><label>44</label><element-citation publication-type="journal" id="rf0220"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Qiao</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name></person-group><article-title>Bioorganic &#x00026; Medicinal Chemistry Antitussive and expectorant activities of licorice and its major compounds</article-title><source>Bioorg. Med. Chem.</source><volume>26</volume><year>2018</year><fpage>278</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">29224994</pub-id></element-citation></ref><ref id="bb0225"><label>45</label><element-citation publication-type="journal" id="rf0225"><person-group person-group-type="author"><name><surname>Kumaki</surname><given-names>Y.</given-names></name><name><surname>Wandersee</surname><given-names>M.K.</given-names></name><name><surname>Smith</surname><given-names>A.J.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Simmons</surname><given-names>G.</given-names></name><name><surname>Nelson</surname><given-names>N.M.</given-names></name><name><surname>Bailey</surname><given-names>K.W.</given-names></name><name><surname>Vest</surname><given-names>Z.G.</given-names></name><name><surname>Li</surname><given-names>J.K.K.</given-names></name><name><surname>Chan</surname><given-names>P.K.S.</given-names></name><name><surname>Smee</surname><given-names>D.F.</given-names></name></person-group><article-title>Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin</article-title><source>Antivir. Res.</source><volume>90</volume><year>2011</year><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">21338626</pub-id></element-citation></ref><ref id="bb0230"><label>46</label><element-citation publication-type="journal" id="rf0230"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Dhanjal</surname><given-names>J.K.</given-names></name><name><surname>Kaul</surname><given-names>S.C.</given-names></name><name><surname>Wadhwa</surname><given-names>R.</given-names></name><name><surname>Sundar</surname><given-names>D.</given-names></name></person-group><article-title>Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M<sup>pro</sup>) of SARS-CoV-2 and inhibit its activity</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1772108</pub-id></element-citation></ref><ref id="bb0235"><label>47</label><element-citation publication-type="journal" id="rf0235"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>D.H.</given-names></name><name><surname>Kwon</surname><given-names>H.Y.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Chang</surname><given-names>E.J.</given-names></name><name><surname>Kim</surname><given-names>M.B.</given-names></name><name><surname>Yoon</surname><given-names>S.K.</given-names></name><name><surname>Song</surname><given-names>E.Y.</given-names></name><name><surname>Yoon</surname><given-names>D.Y.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Choi</surname><given-names>I.S.</given-names></name><name><surname>Choi</surname><given-names>Y.K.</given-names></name></person-group><article-title>Inhibition of hepatitis B virus by an aqueous extract of Agrimonia eupatoria L</article-title><source>Phytother. Res.</source><volume>19</volume><year>2005</year><fpage>355</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">16041735</pub-id></element-citation></ref><ref id="bb0240"><label>48</label><element-citation publication-type="journal" id="rf0240"><person-group person-group-type="author"><name><surname>Leite Junior</surname><given-names>J.B.</given-names></name><name><surname>de Mello Bastos</surname><given-names>J.M.</given-names></name><name><surname>Samuels</surname><given-names>R.I.</given-names></name><name><surname>Carey</surname><given-names>R.J.</given-names></name><name><surname>Carrera</surname><given-names>M.P.</given-names></name></person-group><article-title>Reversal of morphine conditioned behavior by an anti-dopaminergic post-trial drug treatment during re-consolidation</article-title><source>Behav. Brain Res.</source><volume>359</volume><year>2019</year><fpage>771</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">30114434</pub-id></element-citation></ref><ref id="bb0245"><label>49</label><element-citation publication-type="journal" id="rf0245"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.W.</given-names></name><name><surname>Tsai</surname><given-names>F.J.</given-names></name><name><surname>Tsai</surname><given-names>C.H.</given-names></name><name><surname>Lai</surname><given-names>C.C.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Ho</surname><given-names>T.Y.</given-names></name><name><surname>Hsieh</surname><given-names>C.C.</given-names></name><name><surname>Chao</surname><given-names>P.D.L.</given-names></name></person-group><article-title>Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds</article-title><source>Antivir. Res.</source><volume>68</volume><year>2005</year><fpage>36</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16115693</pub-id></element-citation></ref><ref id="bb0250"><label>50</label><element-citation publication-type="journal" id="rf0250"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Morrow</surname><given-names>T.J.</given-names></name><name><surname>Roy</surname><given-names>J.A.K.</given-names></name><name><surname>Terry</surname><given-names>L.C.</given-names></name><name><surname>Casey</surname><given-names>K.L.</given-names></name></person-group><article-title>Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia. Evidence-based Complement</article-title><source>Altern. Med.</source><volume>479</volume><year>1989</year><fpage>306</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1155/2020/1021258</pub-id></element-citation></ref><ref id="bb0255"><label>51</label><element-citation publication-type="journal" id="rf0255"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)</article-title><source>Cochrane Database Syst. Rev.</source><volume>10</volume><year>2012</year><object-id pub-id-type="publisher-id">CD004882</object-id></element-citation></ref><ref id="bb0260"><label>52</label><element-citation publication-type="journal" id="rf0260"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name></person-group><article-title>Phytomedicine Antitussive, expectorant, and bronchodilating effects of quinazoline parts of <italic>Peganum harmala</italic> L</article-title><source>Phytomedicine</source><volume>22</volume><year>2015</year><fpage>1088</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">26547531</pub-id></element-citation></ref><ref id="bb0265"><label>53</label><element-citation publication-type="journal" id="rf0265"><person-group person-group-type="author"><name><surname>Lomba</surname><given-names>L.A.</given-names></name><name><surname>Vogt</surname><given-names>P.H.</given-names></name><name><surname>Souza</surname><given-names>V.E.P.</given-names></name><name><surname>Leite-Avalca</surname><given-names>M.C.G.</given-names></name><name><surname>Verdan</surname><given-names>M.H.</given-names></name><name><surname>Stefanello</surname><given-names>M.E.A.</given-names></name><name><surname>Zampronio</surname><given-names>A.R.</given-names></name></person-group><article-title>A naphthoquinone from Sinningia canescens inhibits inflammation and fever in mice</article-title><source>Inflammation</source><volume>40</volume><year>2017</year><fpage>1051</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">28332176</pub-id></element-citation></ref><ref id="bb0270"><label>54</label><element-citation publication-type="journal" id="rf0270"><person-group person-group-type="author"><name><surname>Lung</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Y.S.</given-names></name><name><surname>Yang</surname><given-names>Y.H.</given-names></name><name><surname>Chou</surname><given-names>Y.L.</given-names></name><name><surname>Shu</surname><given-names>L.H.</given-names></name><name><surname>Cheng</surname><given-names>Y.C.</given-names></name><name><surname>Liu</surname><given-names>H.T.</given-names></name><name><surname>Wu</surname><given-names>C.Y.</given-names></name></person-group><article-title>The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase</article-title><source>J. Med. Virol.</source><volume>92</volume><year>2020</year><fpage>693</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">32167173</pub-id></element-citation></ref><ref id="bb0275"><label>55</label><element-citation publication-type="journal" id="rf0275"><person-group person-group-type="author"><name><surname>Lurie</surname><given-names>N.</given-names></name><name><surname>Saville</surname><given-names>M.</given-names></name><name><surname>Hatchett</surname><given-names>R.</given-names></name><name><surname>Halton</surname><given-names>J.</given-names></name></person-group><article-title>Developing Covid-19 vaccines at pandemic speed</article-title><source>N. Engl. J. Med.</source><volume>382</volume><year>2020</year><fpage>1969</fpage><lpage>1973</lpage><pub-id pub-id-type="pmid">32227757</pub-id></element-citation></ref><ref id="bb0280"><label>56</label><element-citation publication-type="journal" id="rf0280"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Oksman-Caldentey</surname><given-names>K.M.</given-names></name><name><surname>Rischer</surname><given-names>H.</given-names></name></person-group><article-title>Agrobacterium-mediated genetic transformation of the medicinal plant Veratrum dahuricum</article-title><source>Plants</source><volume>9</volume><year>2020</year><fpage>191</fpage></element-citation></ref><ref id="bb0285"><label>57</label><element-citation publication-type="journal" id="rf0285"><person-group person-group-type="author"><name><surname>Mangprayool</surname><given-names>T.</given-names></name><name><surname>Kupittayanant</surname><given-names>S.</given-names></name><name><surname>Chudapongse</surname><given-names>N.</given-names></name></person-group><article-title>Participation of citral in the bronchodilatory effect of ginger oil and possible mechanism of action</article-title><source>Fitoterapia</source><volume>89</volume><year>2013</year><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">23685048</pub-id></element-citation></ref><ref id="bb0290"><label>58</label><element-citation publication-type="journal" id="rf0290"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-V&#x000e1;zquez</surname><given-names>M.</given-names></name><name><surname>Ram&#x000ed;rez Apan</surname><given-names>T.O.</given-names></name><name><surname>Aguilar</surname><given-names>M.H.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name></person-group><article-title>Analgesic and antipyretic activities of an aqueous extract and of the flavone linarin of buddleia cordata</article-title><source>Planta Med.</source><volume>62</volume><year>1996</year><fpage>137</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">8657746</pub-id></element-citation></ref><ref id="bb0295"><label>59</label><element-citation publication-type="journal" id="rf0295"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>J.K.</given-names></name><name><surname>S&#x000e9;ron</surname><given-names>K.</given-names></name><name><surname>Labitt</surname><given-names>R.N.</given-names></name><name><surname>Danneels</surname><given-names>A.</given-names></name><name><surname>Palmer</surname><given-names>K.E.</given-names></name><name><surname>Whittaker</surname><given-names>G.R.</given-names></name><name><surname>Dubuisson</surname><given-names>J.</given-names></name><name><surname>Belouzard</surname><given-names>S.</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin</article-title><source>Antivir. Res.</source><volume>133</volume><year>2016</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">27424494</pub-id></element-citation></ref><ref id="bb0300"><label>60</label><element-citation publication-type="journal" id="rf0300"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>K.B.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>Y.I.</given-names></name><name><surname>Song</surname><given-names>I.J.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Cho</surname><given-names>H.S.</given-names></name><name><surname>Jeon</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name></person-group><article-title>Development of Systems for the Production of plant-derived biopharmaceuticals</article-title><source>Plants (Basel)</source><volume>24</volume><issue>9</issue><year>2019</year><fpage>30</fpage></element-citation></ref><ref id="bb0305"><label>61</label><element-citation publication-type="journal" id="rf0305"><person-group person-group-type="author"><name><surname>Muhammad</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>B.</given-names></name><name><surname>Iqbal</surname><given-names>Z.</given-names></name><name><surname>Khan</surname><given-names>A.Z.</given-names></name><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Khan</surname><given-names>Kashif</given-names></name><name><surname>Alamzeb</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name><name><surname>Khan</surname><given-names>Khalid</given-names></name><name><surname>Lal Badshah</surname><given-names>S.</given-names></name><name><surname>Ullah</surname><given-names>A.</given-names></name><name><surname>Muhammad</surname><given-names>S.</given-names></name><name><surname>Jan</surname><given-names>M.T.</given-names></name><name><surname>Nadeem</surname><given-names>S.</given-names></name><name><surname>Kabir</surname><given-names>N.</given-names></name></person-group><article-title>Viscosine as a potent and safe antipyretic agent evaluated by yeast-induced pyrexia model and molecular docking studies</article-title><source>ACS Omega</source><volume>4</volume><year>2019</year><fpage>14188</fpage><lpage>14192</lpage><pub-id pub-id-type="pmid">31508540</pub-id></element-citation></ref><ref id="bb0310"><label>62</label><element-citation publication-type="journal" id="rf0310"><person-group person-group-type="author"><name><surname>Nikhat</surname><given-names>S.</given-names></name><name><surname>Fazil</surname><given-names>M.</given-names></name></person-group><article-title>Overview of Covid-19; its prevention and management in the light of Unani medicine</article-title><source>Sci. Total Environ.</source><volume>728</volume><year>2020</year><fpage>138859</fpage><pub-id pub-id-type="pmid">32334163</pub-id></element-citation></ref><ref id="bb0315"><label>63</label><element-citation publication-type="journal" id="rf0315"><person-group person-group-type="author"><name><surname>Okebe</surname><given-names>J.</given-names></name><name><surname>Bojang</surname><given-names>K.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>U.</given-names></name></person-group><article-title>Use of artemisinin and its derivatives for the treatment of malaria in children</article-title><source>Pediatr. Infect. Dis. J.</source><volume>33</volume><year>2014</year><fpage>522</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">24736442</pub-id></element-citation></ref><ref id="bb0320"><label>64</label><element-citation publication-type="journal" id="rf0320"><person-group person-group-type="author"><name><surname>Okuyama</surname><given-names>E.</given-names></name><name><surname>Umeyama</surname><given-names>K.</given-names></name><name><surname>Yamazaki</surname><given-names>M.</given-names></name><name><surname>Kinoshita</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name></person-group><article-title>Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta</article-title><source>Planta Med.</source><volume>61</volume><year>1995</year><fpage>113</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">7753915</pub-id></element-citation></ref><ref id="bb0325"><label>65</label><element-citation publication-type="journal" id="rf0325"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Jeong</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>D.W.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Kwon</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name><name><surname>Ryu</surname><given-names>Y.B.</given-names></name></person-group><article-title>Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases</article-title><source>Bioorg. Med. Chem.</source><volume>20</volume><year>2012</year><fpage>5928</fpage><lpage>5935</lpage><pub-id pub-id-type="pmid">22884354</pub-id></element-citation></ref><ref id="bb0330"><label>66</label><element-citation publication-type="journal" id="rf0330"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Yuk</surname><given-names>H.J.</given-names></name><name><surname>Ryu</surname><given-names>H.W.</given-names></name><name><surname>Lim</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Ryu</surname><given-names>Y.B.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name></person-group><article-title>Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors</article-title><source>J. Enzyme Inhib. Med. Chem.</source><volume>2</volume><year>2017</year><fpage>504</fpage><lpage>515</lpage></element-citation></ref><ref id="bb0335"><label>67</label><element-citation publication-type="journal" id="rf0335"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name><name><surname>Nam</surname><given-names>Y.J.</given-names></name><name><surname>Han</surname><given-names>J.H.</given-names></name><name><surname>Byun</surname><given-names>H.D.</given-names></name><name><surname>Song</surname><given-names>M.J.</given-names></name><name><surname>Oh</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>S.G.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name></person-group><article-title>Identification and characterization of baicalin as a phosphodiesterase 4 inhibitor</article-title><source>Phyther. Res.</source><volume>30</volume><year>2016</year><fpage>144</fpage><lpage>151</lpage></element-citation></ref><ref id="bb0340"><label>68</label><element-citation publication-type="journal" id="rf0340"><person-group person-group-type="author"><name><surname>Paton</surname><given-names>K.F.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Crowley</surname><given-names>R.S.</given-names></name><name><surname>Harper</surname><given-names>J.L.</given-names></name><name><surname>Prisinzano</surname><given-names>T.E.</given-names></name><name><surname>Kivell</surname><given-names>B.M.</given-names></name><name><surname>1School</surname></name></person-group><article-title>The analgesic and anti-inflammatory effects of Salvinorin A analogue &#x003b2;-tetrahydropyran Salvinorin B in mice</article-title><source>Eur. J. Pain</source><volume>21</volume><year>2017</year><fpage>1039</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">28158929</pub-id></element-citation></ref><ref id="bb0345"><label>69</label><element-citation publication-type="journal" id="rf0345"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Prasad</surname><given-names>M.</given-names></name></person-group><article-title>SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence</article-title><source>J. Genet.</source><volume>99</volume><year>2020</year><fpage>37</fpage><pub-id pub-id-type="pmid">32482926</pub-id></element-citation></ref><ref id="bb0350"><label>70</label><element-citation publication-type="journal" id="rf0350"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Muthamilarasan</surname><given-names>M.</given-names></name><name><surname>Prasad</surname><given-names>M.</given-names></name></person-group><article-title>Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules</article-title><source>Plant Cell Rep.</source><year>2020</year><pub-id pub-id-type="doi">10.1007/s00299-020-02560-w</pub-id></element-citation></ref><ref id="bb0355"><label>71</label><element-citation publication-type="journal" id="rf0355"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name></person-group><article-title>Folium Sennae and emodin reverse airway smooth muscle contraction</article-title><source>Cell Biol. Int.</source><year>2020</year><pub-id pub-id-type="doi">10.1002/cbin.11393</pub-id></element-citation></ref><ref id="bb0360"><label>72</label><element-citation publication-type="journal" id="rf0360"><person-group person-group-type="author"><name><surname>Rauf</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>R.</given-names></name><name><surname>Khan</surname><given-names>H.</given-names></name><name><surname>Ullah</surname><given-names>B.</given-names></name><name><surname>Pervez</surname><given-names>S.</given-names></name></person-group><article-title>Antipyretic and antinociceptive potential of extract/fractions of Potentilla evestita and its isolated compound, acacetin</article-title><source>BMC Complement. Altern. Med.</source><volume>14</volume><year>2014</year><fpage>448</fpage><pub-id pub-id-type="pmid">25407486</pub-id></element-citation></ref><ref id="bb0365"><label>73</label><element-citation publication-type="journal" id="rf0365"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>H.W.</given-names></name><name><surname>Lee</surname><given-names>S.U.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>H.H.</given-names></name><name><surname>Son</surname><given-names>T.H.</given-names></name><name><surname>Kim</surname><given-names>Y.U.</given-names></name><name><surname>Yuk</surname><given-names>H.J.</given-names></name><name><surname>Ro</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>C.K.</given-names></name><name><surname>Hong</surname><given-names>S.T.</given-names></name><name><surname>Oh</surname><given-names>S.R.</given-names></name></person-group><article-title>3-Methoxy-catalposide inhibits inflammatory effects in lipopolysaccharide-stimulated RAW264.7 macrophages</article-title><source>Cytokine</source><volume>91</volume><year>2017</year><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">28011397</pub-id></element-citation></ref><ref id="bb0370"><label>74</label><element-citation publication-type="journal" id="rf0370"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>Y.B.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Seo</surname><given-names>W.D.</given-names></name><name><surname>Chang</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Rho</surname><given-names>M.C.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name></person-group><article-title>SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii</article-title><source>Bioorg. Med. Chem. Lett.</source><volume>20</volume><year>2010</year><fpage>1873</fpage><lpage>1876</lpage><pub-id pub-id-type="pmid">20167482</pub-id></element-citation></ref><ref id="bb0375"><label>75</label><element-citation publication-type="journal" id="rf0375"><person-group person-group-type="author"><name><surname>Saadat</surname><given-names>S.</given-names></name><name><surname>Naghdi</surname><given-names>F.</given-names></name><name><surname>Ghorani</surname><given-names>V.</given-names></name><name><surname>Rakhshandeh</surname><given-names>H.</given-names></name><name><surname>Boskabady</surname><given-names>M.H.</given-names></name></person-group><article-title>Histamine (H1) receptors, cyclooxygenase pathway and nitric oxide formation involved in rat tracheal smooth muscle relaxant effect of berberine</article-title><source>Iran. J. Allergy Asthma Immunol.</source><volume>18</volume><year>2019</year><fpage>320</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">31522439</pub-id></element-citation></ref><ref id="bb0380"><label>76</label><element-citation publication-type="journal" id="rf0380"><person-group person-group-type="author"><name><surname>Sampangi-Ramaiah</surname><given-names>M.H.</given-names></name><name><surname>Vishwakarma</surname><given-names>R.</given-names></name><name><surname>Shaanker</surname><given-names>U.</given-names></name></person-group><article-title>Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease</article-title><source>Curr. Sci.</source><volume>118</volume><year>2020</year><fpage>1087</fpage><lpage>1092</lpage></element-citation></ref><ref id="bb0385"><label>77</label><element-citation publication-type="journal" id="rf0385"><person-group person-group-type="author"><name><surname>Sehailia</surname><given-names>M.</given-names></name><name><surname>Chemat</surname><given-names>S.</given-names></name></person-group><article-title>In-silico studies of antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19</article-title><source>ChemRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.12098652.v1</pub-id></element-citation></ref><ref id="bb0390"><label>78</label><element-citation publication-type="journal" id="rf0390"><person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J.</given-names></name></person-group><article-title>Influenza virus variants with reduced susceptibility to inhibition by a polyphenol extract from Geranium sanguineum L</article-title><source>Pharmazie</source><volume>58</volume><year>2003</year><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">12622254</pub-id></element-citation></ref><ref id="bb0395"><label>79</label><element-citation publication-type="journal" id="rf0395"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ye</surname><given-names>F.</given-names></name><name><surname>Cen</surname><given-names>S.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name></person-group><article-title>High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses</article-title><source>J. Virol.</source><volume>93</volume><year>2019</year><comment>(e00023&#x02013;19)</comment></element-citation></ref><ref id="bb0400"><label>80</label><element-citation publication-type="journal" id="rf0400"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>M.L.</given-names></name><name><surname>Wang</surname><given-names>C.H.</given-names></name><name><surname>Lin</surname><given-names>C.H.</given-names></name><name><surname>Zhou</surname><given-names>N.</given-names></name><name><surname>Te Kao</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>D.C.</given-names></name></person-group><article-title>Luteolin attenuates airway mucus overproduction via inhibition of the GABAergic system</article-title><source>Sci. Rep.</source><volume>6</volume><year>2016</year><fpage>32756</fpage><pub-id pub-id-type="pmid">27595800</pub-id></element-citation></ref><ref id="bb0405"><label>81</label><element-citation publication-type="journal" id="rf0405"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>I.S.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Shin</surname><given-names>N.R.</given-names></name><name><surname>Jeon</surname><given-names>C.M.</given-names></name><name><surname>Kwon</surname><given-names>O.K.</given-names></name><name><surname>Chin</surname><given-names>Y.W.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Oh</surname><given-names>S.R.</given-names></name></person-group><article-title>Homoegonol attenuates the asthmatic responses induced by ovalbumin challenge</article-title><source>Arch. Pharm. Res.</source><volume>37</volume><year>2014</year><fpage>1201</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">24424605</pub-id></element-citation></ref><ref id="bb0410"><label>82</label><element-citation publication-type="journal" id="rf0410"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>I.S.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Jeon</surname><given-names>C.M.</given-names></name><name><surname>Shin</surname><given-names>N.R.</given-names></name><name><surname>Kwon</surname><given-names>O.K.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>J.C.</given-names></name><name><surname>Oh</surname><given-names>S.R.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name></person-group><article-title>Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression</article-title><source>Food Chem. Toxicol.</source><volume>62</volume><year>2013</year><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">24051194</pub-id></element-citation></ref><ref id="bb0415"><label>83</label><element-citation publication-type="journal" id="rf0415"><person-group person-group-type="author"><name><surname>Shrimali</surname><given-names>D.</given-names></name><name><surname>Shanmugam</surname><given-names>M.K.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>B.K.H.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name></person-group><article-title>Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer</article-title><source>Cancer Lett.</source><volume>341</volume><year>2013</year><fpage>139</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">23962559</pub-id></element-citation></ref><ref id="bb0420"><label>84</label><element-citation publication-type="journal" id="rf0420"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>S.A.</given-names></name><name><surname>Rahman</surname><given-names>A.</given-names></name><name><surname>Rahman</surname><given-names>M.O.</given-names></name><name><surname>Akbar</surname><given-names>M.A.</given-names></name><name><surname>Ali</surname><given-names>M.A.</given-names></name><name><surname>Al-Hemaid</surname><given-names>F.M.A.</given-names></name><name><surname>Elshikh</surname><given-names>M.S.</given-names></name><name><surname>Farah</surname><given-names>M.A.</given-names></name></person-group><article-title>A novel triterpenoid 16-hydroxy betulinic acid isolated from Mikania cordata attributes multi-faced pharmacological activities</article-title><source>Saudi J. Biol. Sci.</source><volume>26</volume><year>2019</year><fpage>554</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">30899171</pub-id></element-citation></ref><ref id="bb0425"><label>85</label><element-citation publication-type="journal" id="rf0425"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>K.S.</given-names></name><name><surname>Sinha</surname><given-names>S.K.</given-names></name><name><surname>Prasad</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Bithu</surname><given-names>B.S.</given-names></name><name><surname>Sadish Kumar</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name></person-group><article-title>Synthesis and evaluation of novel analogues of mangiferin as potent antipyretic</article-title><source>Asian Pac J Trop Med</source><volume>4</volume><year>2011</year><fpage>866</fpage><lpage>869</lpage><pub-id pub-id-type="pmid">22078948</pub-id></element-citation></ref><ref id="bb0430"><label>86</label><element-citation publication-type="journal" id="rf0430"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>R.A.K.</given-names></name><name><surname>Mistry</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group><article-title>A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes</article-title><source>Nutr. Metab.</source><volume>12</volume><year>2015</year><fpage>20</fpage></element-citation></ref><ref id="bb0435"><label>87</label><element-citation publication-type="journal" id="rf0435"><person-group person-group-type="author"><name><surname>Thuy</surname><given-names>B.T.P.</given-names></name><name><surname>My</surname><given-names>T.T.A.</given-names></name><name><surname>Hai</surname><given-names>N.T.T.</given-names></name><name><surname>Hieu</surname><given-names>L.T.</given-names></name><name><surname>Hoa</surname><given-names>T.T.</given-names></name><name><surname>Thi Phuong Loan</surname><given-names>H.</given-names></name><name><surname>Triet</surname><given-names>N.T.</given-names></name><name><surname>Anh</surname><given-names>T.T.V.</given-names></name><name><surname>Quy</surname><given-names>P.T.</given-names></name><name><surname>Tat</surname><given-names>P.V.</given-names></name><name><surname>Hue</surname><given-names>N.V.</given-names></name></person-group><article-title>Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil</article-title><source>ACS Omega</source><volume>5</volume><year>2020</year><fpage>8312</fpage><lpage>8320</lpage><pub-id pub-id-type="pmid">32363255</pub-id></element-citation></ref><ref id="bb0440"><label>88</label><element-citation publication-type="journal" id="rf0440"><person-group person-group-type="author"><name><surname>Toney</surname><given-names>J.H.</given-names></name><name><surname>Navas-Mart&#x000ed;n</surname><given-names>S.</given-names></name><name><surname>Weiss</surname><given-names>S.R.</given-names></name><name><surname>Koeller</surname><given-names>A.</given-names></name></person-group><article-title>Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design</article-title><source>J. Med. Chem.</source><volume>47</volume><year>2004</year><fpage>1079</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">14971887</pub-id></element-citation></ref><ref id="bb0445"><label>89</label><element-citation publication-type="journal" id="rf0445"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Duan</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Hua</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>F.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Chang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>TCM treatment of infectious atypical pneumonia--a report of 16 cases</article-title><source>J. Tradit. Chin. Med.</source><volume>24</volume><year>2004</year><fpage>266</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">15688692</pub-id></element-citation></ref><ref id="bb0450"><label>90</label><element-citation publication-type="journal" id="rf0450"><person-group person-group-type="author"><name><surname>Vane</surname><given-names>J.R.</given-names></name><name><surname>Botting</surname><given-names>R.M.</given-names></name></person-group><article-title>The mechanism of action of aspirin</article-title><source>Thromb. Res.</source><volume>110</volume><year>2003</year><fpage>255</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">14592543</pub-id></element-citation></ref><ref id="bb0455"><label>91</label><element-citation publication-type="journal" id="rf0455"><person-group person-group-type="author"><name><surname>Vel&#x000e1;zquez</surname><given-names>F.</given-names></name><name><surname>Manr&#x000ed;quez</surname><given-names>R.</given-names></name><name><surname>Maya</surname><given-names>L.</given-names></name><name><surname>Barrientos</surname><given-names>L.</given-names></name><name><surname>L&#x000f3;pez-Dellamary</surname><given-names>F.</given-names></name></person-group><article-title>Phenacetin isolated from Bursera grandifolia, a herbal remedy with antipyretic properties</article-title><source>Nat. Prod. Commun.</source><volume>4</volume><year>2009</year><fpage>1575</fpage><lpage>1576</lpage><pub-id pub-id-type="pmid">19967994</pub-id></element-citation></ref><ref id="bb0460"><label>92</label><element-citation publication-type="journal" id="rf0460"><person-group person-group-type="author"><name><surname>Vellingiri</surname><given-names>B.</given-names></name><name><surname>Jayaramayya</surname><given-names>K.</given-names></name><name><surname>Iyer</surname><given-names>M.</given-names></name><name><surname>Narayanasamy</surname><given-names>A.</given-names></name><name><surname>Govindasamy</surname><given-names>V.</given-names></name><name><surname>Giridharan</surname><given-names>B.</given-names></name><name><surname>Ganesan</surname><given-names>S.</given-names></name><name><surname>Venugopal</surname><given-names>A.</given-names></name><name><surname>Venkatesan</surname><given-names>D.</given-names></name><name><surname>Ganesan</surname><given-names>H.</given-names></name><name><surname>Rajagopalan</surname><given-names>K.</given-names></name></person-group><article-title>COVID-19: a promising cure for the global panic</article-title><source>Sci. Total Environ.</source><volume>4</volume><year>2020</year><fpage>725</fpage><comment>(138277)</comment></element-citation></ref><ref id="bb0465"><label>93</label><element-citation publication-type="journal" id="rf0465"><person-group person-group-type="author"><name><surname>Vu&#x0010d;kovic</surname><given-names>S.</given-names></name><name><surname>Srebro</surname><given-names>D.</given-names></name><name><surname>Vujovic</surname><given-names>K.S.</given-names></name><name><surname>Vu&#x0010d;etic</surname><given-names>&#x0010c;.</given-names></name><name><surname>Prostran</surname><given-names>M.</given-names></name></person-group><article-title>Cannabinoids and pain: new insights from old molecules</article-title><source>Front. Pharmacol.</source><volume>9</volume><year>2018</year><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">29387012</pub-id></element-citation></ref><ref id="bb0470"><label>94</label><element-citation publication-type="journal" id="rf0470"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Nie</surname><given-names>L.</given-names></name><name><surname>Long</surname><given-names>X.</given-names></name></person-group><article-title>Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis</article-title><source>J. Ethnopharmacol.</source><volume>139</volume><year>2012</year><fpage>189</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">22101082</pub-id></element-citation></ref><ref id="bb0475"><label>95</label><element-citation publication-type="journal" id="rf0475"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ou</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Fitoterapia Antitussive, expectorant and anti-in fl ammatory alkaloids from Bulbus Fritillariae Cirrhosae</article-title><source>Fitoterapia</source><volume>82</volume><year>2011</year><fpage>1290</fpage><lpage>1294</lpage><pub-id pub-id-type="pmid">21958967</pub-id></element-citation></ref><ref id="bb0480"><label>96</label><element-citation publication-type="journal" id="rf0480"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Fast identification of possible drug treatment of coronavirus Disease-19 (COVID-19) through computational drug repurposing study</article-title><source>J. Chem. Inf. Model.</source><year>2020</year><pub-id pub-id-type="doi">10.1021/acs.jcim.0c00179</pub-id></element-citation></ref><ref id="bb0485"><label>97</label><element-citation publication-type="journal" id="rf0485"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name></person-group><article-title>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</article-title><source>Cell Res.</source><volume>30</volume><year>2020</year><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">32020029</pub-id></element-citation></ref><ref id="bb0490"><label>98</label><element-citation publication-type="journal" id="rf0490"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>L.</given-names></name></person-group><article-title>Evaluation of pharmacological relaxation effect of the natural product naringin on in vitro cultured airway smooth muscle cells and in vivo ovalbumin-induced asthma Balb/c mice</article-title><source>Biomed. Reports</source><volume>5</volume><year>2016</year><fpage>715</fpage><lpage>722</lpage></element-citation></ref><ref id="bb0495"><label>99</label><element-citation publication-type="journal" id="rf0495"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>C.C.</given-names></name><name><surname>Shyur</surname><given-names>L.F.</given-names></name><name><surname>Jan</surname><given-names>J.T.</given-names></name><name><surname>Liang</surname><given-names>P.H.</given-names></name><name><surname>Kuo</surname><given-names>C.J.</given-names></name><name><surname>Arulselvan</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>J.B.</given-names></name><name><surname>Kuo</surname><given-names>S.C.</given-names></name><name><surname>Yang</surname><given-names>N.S.</given-names></name></person-group><article-title>Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication</article-title><source>J. Tradit. Complement. Med.</source><volume>1</volume><year>2011</year><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">24716104</pub-id></element-citation></ref><ref id="bb0500"><label>100</label><element-citation publication-type="journal" id="rf0500"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group><article-title>Antitussive, expectorant, and anti-inflammatory activities of four caffeoylquinic acids isolated from Tussilago farfara</article-title><source>Pharm. Biol.</source><volume>54</volume><year>2016</year><fpage>1117</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">26439905</pub-id></element-citation></ref><ref id="bb0505"><label>101</label><element-citation publication-type="journal" id="rf0505"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Islam</surname><given-names>M.S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective</article-title><source>Int. J. Biol. Sci.</source><volume>16</volume><year>2020</year><fpage>1708</fpage><lpage>1717</lpage><pub-id pub-id-type="pmid">32226288</pub-id></element-citation></ref><ref id="bb0510"><label>102</label><element-citation publication-type="journal" id="rf0510"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Yuan</surname><given-names>K.</given-names></name><name><surname>Qu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name></person-group><article-title>Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells</article-title><source>J. Virol.</source><volume>78</volume><year>2004</year><fpage>11334</fpage><lpage>11339</lpage><pub-id pub-id-type="pmid">15452254</pub-id></element-citation></ref><ref id="bb0515"><label>103</label><element-citation publication-type="journal" id="rf0515"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>Expectorant, antitussive, anti-in fl ammatory activities and compositional analysis of <italic>Aster tataricus</italic></article-title><source>J. Ethnopharmacol.</source><volume>164</volume><year>2015</year><fpage>328</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">25701752</pub-id></element-citation></ref><ref id="bb0520"><label>104</label><element-citation publication-type="journal" id="rf0520"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.M.</given-names></name><name><surname>Liu</surname><given-names>X.M.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name></person-group><article-title>Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence</article-title><source>World J. Gastroenterol.</source><volume>10</volume><year>2004</year><fpage>3500</fpage><lpage>3505</lpage><pub-id pub-id-type="pmid">15526373</pub-id></element-citation></ref><ref id="bb0525"><label>105</label><element-citation publication-type="journal" id="rf0525"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.Z.</given-names></name><name><surname>Fu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>S.P.</given-names></name></person-group><article-title>Anti-asthmatic effects of oxymatrine in a mouse model of allergic asthma through regulating CD40 signaling</article-title><source>Chin. J. Nat. Med.</source><volume>13</volume><year>2015</year><fpage>368</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">25986286</pub-id></element-citation></ref><ref id="bb0530"><label>106</label><element-citation publication-type="journal" id="rf0530"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>E.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><article-title>Inhibition of allergic airway inflammation through the blockage of NF-&#x003ba;B activation by ellagic acid in an ovalbumin-induced mouse asthma model</article-title><source>Food Funct.</source><volume>5</volume><year>2014</year><fpage>2106</fpage><lpage>2112</lpage><pub-id pub-id-type="pmid">24998475</pub-id></element-citation></ref><ref id="bb0535"><label>107</label><element-citation publication-type="journal" id="rf0535"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>F.</given-names></name></person-group><article-title>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</article-title><source>Cell Discov.</source><volume>6</volume><year>2020</year><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">31934347</pub-id></element-citation></ref><ref id="bb0540"><label>108</label><element-citation publication-type="journal" id="rf0540"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>P.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Ling</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Saitoh</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Qin</surname><given-names>C.</given-names></name></person-group><article-title>Procyanidins and butanol extract of Cinnamomi cortex inhibit SARS-CoV infection</article-title><source>Antivir. Res.</source><volume>82</volume><year>2009</year><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">19428598</pub-id></element-citation></ref><ref id="bb1000"><label>109</label><element-citation publication-type="journal" id="rf1000"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>YB</given-names></name><name><surname>Jeong</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name><name><surname>Rho</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>WS</given-names></name></person-group><article-title>Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.</article-title><source>Bioorg Med Chem</source><volume>18</volume><year>2010</year><fpage>7940</fpage><lpage>7947</lpage><pub-id pub-id-type="pmid">20934345</pub-id></element-citation></ref></ref-list><ack id="ac0005"><title>Acknowledgements</title><p id="p0080">Authors' work in this area is supported by <funding-source id="gts0005">J.C. Bose National Fellowship Grant of Department of Science and Technology, Government of India</funding-source> (File No.: JCB/2018/000001). N.S. acknowledges the <funding-source id="gts0010">SERB Women Excellence Award from Science and Engineering Research Board, Govt. of India</funding-source> (File No. WEA/2020/000004). A.P. acknowledges the <funding-source id="gts0015">Council for Scientific and Industrial Research, Govt. of India</funding-source> for research fellowship. Authors are thankful to DBT-eLibrary Consortium (DeLCON) for providing access to e-resources.</p></ack></back></article>